[go: up one dir, main page]

TWI859005B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDF

Info

Publication number
TWI859005B
TWI859005B TW112145425A TW112145425A TWI859005B TW I859005 B TWI859005 B TW I859005B TW 112145425 A TW112145425 A TW 112145425A TW 112145425 A TW112145425 A TW 112145425A TW I859005 B TWI859005 B TW I859005B
Authority
TW
Taiwan
Prior art keywords
formula
liquid crystal
polymer
crystal alignment
tetracarboxylic dianhydride
Prior art date
Application number
TW112145425A
Other languages
Chinese (zh)
Other versions
TW202521673A (en
Inventor
王建智
陳志榮
黃菀婷
王博世
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW112145425A priority Critical patent/TWI859005B/en
Application granted granted Critical
Publication of TWI859005B publication Critical patent/TWI859005B/en
Priority to CN202411587192.0A priority patent/CN120025832A/en
Publication of TW202521673A publication Critical patent/TW202521673A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1003Preparatory processes
    • C08G73/1007Preparatory processes from tetracarboxylic acids or derivatives and diamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2379/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
    • C08J2379/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08J2379/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Nonlinear Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

A liquid crystal alignment agent comprises a polymer component (A) and a solvent (B). The polymer component (A) includes a first polymer (A1) obtained from a first mixture by a reaction. The first mixture contains a tetracarboxylic dianhydride component (a1) and a diamine component (b1) wherein the tetracarboxylic dianhydride component (a1) includes a tetracarboxylic dianhydride mixture (a1-1) consisting of a tetracarboxylic dianhydride compound represented by formula (I) and a tetracarboxylic dianhydride compound represented by formula (II). 式(I)

Description

液晶配向劑、液晶配向膜及液晶顯示元件Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

本發明是有關於一種顯示裝置,特別是指一種影像不易殘留的液晶顯示元件,及用於該液晶顯示元件的液晶配向膜與形成該液晶配向膜的液晶配向劑。The present invention relates to a display device, in particular to a liquid crystal display element with less image residue, a liquid crystal alignment film used for the liquid crystal display element, and a liquid crystal alignment agent for forming the liquid crystal alignment film.

以液晶分子的驅動來分類,目前有以縱電場驅動的液晶顯示器及以橫電場驅動的液晶顯示器。該以縱電場驅動的液晶顯示器例如扭曲向列(twisted nematic,簡稱TN)型液晶顯示器及垂直對齊型(vertical alignment,簡稱VA)型液晶顯示器。該以橫電場驅動的液晶顯示器例如平面切換(in-plane switching,簡稱IPS)型液晶顯示器與邊緣場切換(fringe field switching,簡稱FFS)型液晶顯示器。Based on the driving of liquid crystal molecules, there are currently two types of liquid crystal displays: longitudinal electric field driven liquid crystal displays and transverse electric field driven liquid crystal displays. Examples of the longitudinal electric field driven liquid crystal displays are twisted nematic (TN) type liquid crystal displays and vertical alignment (VA) type liquid crystal displays. Examples of the transverse electric field driven liquid crystal displays are in-plane switching (IPS) type liquid crystal displays and fringe field switching (FFS) type liquid crystal displays.

在上述的液晶顯示器中,目前皆是利用摩擦方式的配向處理方法,使液晶配向膜具有能夠使液晶分子沿著一定方向排列的溝槽。目前工業上最普及的配向處理方法是將由聚醯胺酸聚合物及/或聚醯胺酸聚合物經醯亞胺化獲得的聚醯亞胺聚合物所形成液晶配向膜,以綿、尼龍或聚酯等布沿一方向進行摩擦處理。利用摩擦方式的配向處理方法是一種簡單、生產率高且工業上有用的方法。然而,伴隨對液晶顯示器的性能要求提升、畫質精細化及尺寸大型化,為避免因摩擦處理所產生的灰塵及靜電而對液晶配向膜產生的損傷以及配向不均勻性等各種問題產生,藉由照射經偏光的放射線來賦予液晶配向膜具有光配向能力的光配向法油然而生,例如日本專利特開平第H09297313號所揭露的光配向法。In the above-mentioned liquid crystal displays, the alignment treatment method using friction is currently used to make the liquid crystal alignment film have grooves that can align the liquid crystal molecules along a certain direction. The most popular alignment treatment method in the industry is to rub the liquid crystal alignment film formed by polyamide polymer and/or polyimide polymer obtained by imidization of polyamide polymer with cotton, nylon or polyester cloth in one direction. The alignment treatment method using friction is a simple, high-productivity and industrially useful method. However, with the increasing performance requirements for liquid crystal displays, finer picture quality and larger sizes, in order to avoid various problems such as damage to the liquid crystal alignment film caused by dust and static electricity generated by friction processing and alignment non-uniformity, photo-alignment methods have emerged that endow the liquid crystal alignment film with photo-alignment capabilities by irradiating polarized radiation, such as the photo-alignment method disclosed in Japanese Patent Laid-Open No. H09297313.

然而,雖然該光配向法用的液晶配向膜能夠避免利用摩擦方式的配向處理所產生的問題,但目前採用光配向法用的液晶配向膜的液晶顯示器於驅動後因容易有離子電荷殘留的現象發生,而存在有影像殘留的問題,導致無法滿足應用需求。However, although the liquid crystal alignment film used in the optical alignment method can avoid the problems caused by the alignment treatment using the friction method, the liquid crystal display using the liquid crystal alignment film used in the optical alignment method is currently prone to residual ion charges after being driven, resulting in image residue problems, which makes it impossible to meet application requirements.

因此,本發明的第一目的,即在提供一種液晶配向劑。Therefore, the first object of the present invention is to provide a liquid crystal alignment agent.

於是,本發明液晶配向劑,包含聚合物組份(A)及溶劑(B)。該聚合物組份(A)包含第一聚合物(A1)。該第一聚合物(A1)是由第一混合物反應而製得,且該第一混合物包含四羧酸二酐組份(a1)及二胺組份(b1),其中,該四羧酸二酐組份(a1)包括四羧酸二酐混合物(a1-1),且該四羧酸二酐混合物(a1-1)是由式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物所組成, 式(I) 式(II)。 Therefore, the liquid crystal alignment agent of the present invention comprises a polymer component (A) and a solvent (B). The polymer component (A) comprises a first polymer (A1). The first polymer (A1) is prepared by reacting a first mixture, and the first mixture comprises a tetracarboxylic dianhydride component (a1) and a diamine component (b1), wherein the tetracarboxylic dianhydride component (a1) comprises a tetracarboxylic dianhydride mixture (a1-1), and the tetracarboxylic dianhydride mixture (a1-1) is composed of a tetracarboxylic dianhydride compound represented by formula (I) and a tetracarboxylic dianhydride compound represented by formula (II), Formula (I) Formula (II).

本發明的第二目的,即在提供一種液晶配向膜。The second purpose of the present invention is to provide a liquid crystal alignment film.

於是,本發明液晶配向膜,是由上述的液晶配向劑所形成。Therefore, the liquid crystal alignment film of the present invention is formed by the above-mentioned liquid crystal alignment agent.

本發明的第三目的,即在提供一種液晶顯示元件。The third object of the present invention is to provide a liquid crystal display element.

於是,本發明液晶顯示元件,包含上述的液晶配向膜。Therefore, the liquid crystal display element of the present invention includes the above-mentioned liquid crystal alignment film.

本發明的功效在於:透過使用式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物,由本發明液晶配向劑所形成的液晶配向膜用於液晶顯示元件中,能夠賦予該液晶顯示元件具有低殘影性的優點,而能夠滿足應用需求。The effect of the present invention is that by using the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II), the liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention is used in a liquid crystal display element, which can give the liquid crystal display element the advantage of low afterimage and can meet the application requirements.

以下對本發明進行詳細的說明。The present invention is described in detail below.

液晶配向劑Liquid crystal alignment agent

本發明液晶配向劑,包含聚合物組分(A)及溶劑(B)。該聚合物組份(A)包含第一聚合物(A1)。該第一聚合物(A1)是由第一混合物反應而製得,且該第一混合物包含四羧酸二酐組份(a1)及二胺組份(b1),其中,該四羧酸二酐組份(a1)包括四羧酸二酐混合物(a1-1),且該四羧酸二酐混合物(a1-1)是由式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物所組成, 式(I) 式(II)。 The liquid crystal alignment agent of the present invention comprises a polymer component (A) and a solvent (B). The polymer component (A) comprises a first polymer (A1). The first polymer (A1) is prepared by reacting a first mixture, and the first mixture comprises a tetracarboxylic dianhydride component (a1) and a diamine component (b1), wherein the tetracarboxylic dianhydride component (a1) comprises a tetracarboxylic dianhydride mixture (a1-1), and the tetracarboxylic dianhydride mixture (a1-1) is composed of a tetracarboxylic dianhydride compound represented by formula (I) and a tetracarboxylic dianhydride compound represented by formula (II), Formula (I) Formula (II).

第一聚合物First polymer (A1)>(A1)>

該第一聚合物(A1)選自於由包含四羧酸二酐組份(a1)及二胺組份(b1)的反應組成物經反應所形成的聚醯亞胺前驅物及該聚醯亞胺前驅物所形成的醯亞胺化聚合物所組成的群組中的至少一者。舉例而言,該第一聚合物(A1)為具有聚醯胺酸及聚醯胺酸酯的醯亞胺前驅物結構的聚醯亞胺前驅物,或者,該第一聚合物(A1)為該聚醯亞胺前驅物所形成的醯亞胺化聚合物(即聚醯亞胺),或者,該第一聚合物(A1)包含該聚醯亞胺前驅物及該醯亞胺化聚合物。The first polymer (A1) is at least one selected from the group consisting of a polyimide precursor formed by reacting a reaction composition comprising a tetracarboxylic dianhydride component (a1) and a diamine component (b1) and an imidized polymer formed by the polyimide precursor. For example, the first polymer (A1) is a polyimide precursor having an imide precursor structure of polyamic acid and polyamic acid ester, or the first polymer (A1) is an imidized polymer (i.e., polyimide) formed by the polyimide precursor, or the first polymer (A1) includes the polyimide precursor and the imidized polymer.

[[ 四羧酸二酐組份Tetracarboxylic dianhydride component (a1)](a1)]

當該四羧酸二酸酐組份(a1)中的四羧酸二酐混合物(a1-1)未由式(I)所示的四羧酸二酐化合物與式(II)所示的四羧酸二酐化合物所組成時,則包含由該液晶配向劑所形成的液晶配向膜的液晶顯示元件具有高的殘影性。When the tetracarboxylic dianhydride mixture (a1-1) in the tetracarboxylic dianhydride component (a1) is not composed of the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II), the liquid crystal display element including the liquid crystal alignment film formed by the liquid crystal alignment agent has high afterimage properties.

為使由該液晶配向劑所形成的液晶配向膜的液晶顯示元件具有較低的殘影性,較佳地,在本發明的一些實施態樣中,基於該四羧酸二酐組份(a1)的總使用量為100莫耳,該式(I)所示的四羧酸二酐化合物的使用量為50莫耳至99.5莫耳。更佳地,為55莫耳至99.5莫耳,又更佳地,為60莫耳至99.5莫耳。In order to make the liquid crystal display element of the liquid crystal alignment film formed by the liquid crystal alignment agent have lower afterimage property, preferably, in some embodiments of the present invention, based on the total usage of the tetracarboxylic dianhydride component (a1) being 100 mol, the usage of the tetracarboxylic dianhydride compound represented by formula (I) is 50 mol to 99.5 mol. More preferably, it is 55 mol to 99.5 mol, and even more preferably, it is 60 mol to 99.5 mol.

為使由該液晶配向劑所形成的液晶配向膜的液晶顯示元件具有較低的殘影性,較佳地,在本發明的一些實施態樣中,基於該四羧酸二酐組份(a1)的總使用量為100莫耳,該式(II)所示的四羧酸二酐化合物的使用量為0.5莫耳至50莫耳。更佳地,為0.5莫耳至45莫耳,又更佳地,為0.5莫耳至40莫耳。In order to make the liquid crystal display device of the liquid crystal alignment film formed by the liquid crystal alignment agent have lower afterimage property, preferably, in some embodiments of the present invention, based on the total usage of the tetracarboxylic dianhydride component (a1) being 100 mol, the usage of the tetracarboxylic dianhydride compound represented by formula (II) is 0.5 mol to 50 mol. More preferably, it is 0.5 mol to 45 mol, and even more preferably, it is 0.5 mol to 40 mol.

其他四羧酸二酐化合物Other tetracarboxylic dianhydride compounds (a1-2)>(a1-2)>

在本發明的一些實施態樣中,該四羧酸二酐組份(a1)還包括其他四羧酸二酐化合物(a1-2)。In some embodiments of the present invention, the tetracarboxylic dianhydride component (a1) further includes other tetracarboxylic dianhydride compounds (a1-2).

在本發明的一些實施態樣中,該其他四羧酸二酐(a1-2)包含式(A11)所示的四羧酸二酐化合物或其衍生物,其中,該式(A11)所示的四羧酸二酐化合物為 式(A11)。 In some embodiments of the present invention, the other tetracarboxylic dianhydride (a1-2) comprises a tetracarboxylic dianhydride compound represented by formula (A11) or a derivative thereof, wherein the tetracarboxylic dianhydride compound represented by formula (A11) is Formula (A11).

於式(A11)中,X 1'表示式(A11-1)至式(A11-32)所示的結構,其中「*」代表鍵結位置, 式(A11-1)、 式(A11-2)、 式(A11-3)、 式(A11-4)、 式(A11-5)、 式(A11-6)、 式(A11-7)、 式(A11-8)、 式(A11-9)、 式(A11-10)、 式(A11-11)、 式(A11-12)、 式(A11-13)、 式(A11-14)、 式(A11-15)、 式(A11-16)、 式(A11-17)、 式(A11-18)、 式(A11-19)、 式(A11-20)、 式(A11-21)、 式(A11-22)、 式(A11-23)、 式(A11-24)、 式(A11-25)、 式(A11-26)、 式(A11-27)、 式(A11-28)、 式(A11-29)、 式(A11-30)、 式(A11-31)、 式(A11-32)。 In formula (A11), X 1' represents a structure represented by formula (A11-1) to formula (A11-32), wherein "*" represents a bonding position, Formula (A11-1), Formula (A11-2), Formula (A11-3), Formula (A11-4), Formula (A11-5), Formula (A11-6), Formula (A11-7), Formula (A11-8), Formula (A11-9), Formula (A11-10), Formula (A11-11), Formula (A11-12), Formula (A11-13), Formula (A11-14), Formula (A11-15), Formula (A11-16), Formula (A11-17), Formula (A11-18), Formula (A11-19), Formula (A11-20), Formula (A11-21), Formula (A11-22), Formula (A11-23), Formula (A11-24), Formula (A11-25), Formula (A11-26), Formula (A11-27), Formula (A11-28), Formula (A11-29), Formula (A11-30), Formula (A11-31), Formula (A11-32).

於式(A11-1)中,a1為1至12。於式(A11-5)中,X 11'表示單鍵、-O-、-CO-、-COO-、伸苯基、磺醯基或醯胺基,且a1表示0或1。於式(A12-6)中,X 11'及X 12'分別獨立地表示單鍵、-O-、-CO-、-COO-、伸苯基、磺醯基或醯胺基,且複數個X 12'為相同或不同,且a1表示0或1。於式(A11-11)中,a1表示2至6。於式(A11-13)中,a1表示1至2。於式(A11-14)中,X 13'分別獨立地表示氫、鹵素、碳數為1至6的烷基、碳數為2至6的烯基、碳數為2至6的炔基、含有氟且碳數為1至6的一價有機基,或苯基,且複數個X 13'為相同或不同。基於液晶配向性的觀點,較佳地,X 13'表示氫、鹵素、甲基或乙基,更佳地,表示氫或甲基。 In formula (A11-1), a1 is 1 to 12. In formula (A11-5), X 11′ represents a single bond, -O-, -CO-, -COO-, a phenylene group, a sulfonyl group or an amide group, and a1 represents 0 or 1. In formula (A12-6), X 11′ and X 12′ each independently represent a single bond, -O-, -CO-, -COO-, a phenylene group, a sulfonyl group or an amide group, and a plurality of X 12′ are the same or different, and a1 represents 0 or 1. In formula (A11-11), a1 represents 2 to 6. In formula (A11-13), a1 represents 1 to 2. In formula (A11-14), X 13' independently represents hydrogen, a halogen, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group containing fluorine and having 1 to 6 carbon atoms, or a phenyl group, and a plurality of X 13' groups are the same or different. From the viewpoint of liquid crystal alignment, preferably, X 13' represents hydrogen, a halogen, a methyl group or an ethyl group, and more preferably, represents hydrogen or a methyl group.

在本發明的一些實施態樣中,式(A11-5)與式(A11-6)包含但不限於 In some embodiments of the present invention, formula (A11-5) and formula (A11-6) include but are not limited to , , , , , , , , , , , , , , , .

該其他四羧酸二酐(a1-2)可單獨一種使用或混合複數種使用。在本發明的一些實施態樣中,基於該四羧酸二酐組份(a1)的總量為100莫耳,該其他四羧酸二酐(a1-2)的使用量為0莫耳至70莫耳,較佳地,為0莫耳至60莫耳,更佳地,為0莫耳至50莫耳,又更佳地,為0莫耳至10莫耳。The other tetracarboxylic dianhydride (a1-2) can be used alone or in combination. In some embodiments of the present invention, based on the total amount of the tetracarboxylic dianhydride component (a1) being 100 mol, the amount of the other tetracarboxylic dianhydride (a1-2) is 0 mol to 70 mol, preferably 0 mol to 60 mol, more preferably 0 mol to 50 mol, and even more preferably 0 mol to 10 mol.

二胺組份Diamine component (b1)>(b1)>

為賦予包含由該液晶配向劑所形成的液晶配向膜的液晶顯示元件具有較低的殘影性及較佳的安定性,較佳地,在本發明的一些實施態樣中,該二胺組份(b1)包含二胺化合物(b1-1),且該二胺化合物(b1-1)為式(A21-1)至式(A21-2)所示的二胺化合物, 式(A21-1)、 式(A21-2)。 In order to provide a liquid crystal display device including a liquid crystal alignment film formed by the liquid crystal alignment agent with lower afterimage and better stability, preferably, in some embodiments of the present invention, the diamine component (b1) comprises a diamine compound (b1-1), and the diamine compound (b1-1) is a diamine compound represented by formula (A21-1) to formula (A21-2), Formula (A21-1), Formula (A21-2).

於式(A21-1)中,Y 31表示式(A21-3)所示的二價有機基團,且複數個Y 32分別獨立地表示氫或碳數為1至6的烷基。於式(A21-2)中,複數個Y 33分別獨立地表示式(A21-3')所示的二價有機基團, 式(A21-3)、 式(A21-3')。 In formula (A21-1), Y 31 represents a divalent organic group represented by formula (A21-3), and a plurality of Y 32 each independently represents hydrogen or an alkyl group having 1 to 6 carbon atoms. In formula (A21-2), a plurality of Y 33 each independently represents a divalent organic group represented by formula (A21-3'), Formula (A21-3), Formula (A21-3').

於式(A21-3)所示的二價有機基團中,Ar分別獨立地表示二價的苯環、聯苯結構或萘環,且苯環、聯苯結構或萘環的氫原子可被一價取代基團所取代或未被取代;Y 31'代表-(CH 2) n-,n代表2至18的整數,且-(CH 2) n-中的至少一個-CH 2-可被-O-、-C(=O)-或-O-C(=O)-所取代或未被取代;p1表示0或1;「*」代表鍵結位置。 In the divalent organic group represented by formula (A21-3), Ar independently represents a divalent benzene ring, biphenyl structure or naphthyl ring, and the hydrogen atom of the benzene ring, biphenyl structure or naphthyl ring may be substituted by a monovalent substituent group or may not be substituted; Y 31' represents -(CH 2 ) n -, n represents an integer from 2 to 18, and at least one -CH 2 - in -(CH 2 ) n - may be substituted by -O-, -C(=O)- or -OC(=O)- or may not be substituted; p1 represents 0 or 1; "*" represents a bonding position.

於式(A21-3')所示的二價有機基團中,Ar'分別獨立地表示二價的苯環或聯苯結構,且苯環或聯苯結構的氫原子可被一價取代基團所取代或未被取代;Y 33'代表-(CH 2) n-,n代表2至18的整數,且-(CH 2) n-中的至少一個-CH 2-可被-O-、-C(=O)-或-O-C(=O)-所取代或未被取代;p2表示0或1;「*」代表鍵結位置。 In the divalent organic group represented by formula (A21-3'), Ar' independently represents a divalent benzene ring or a biphenyl structure, and the hydrogen atom of the benzene ring or the biphenyl structure may be substituted by a monovalent substituent group or may not be substituted; Y 33' represents -(CH 2 ) n -, n represents an integer from 2 to 18, and at least one -CH 2 - in -(CH 2 ) n - may be substituted by -O-, -C(=O)- or -OC(=O)- or may not be substituted; p2 represents 0 or 1; "*" represents a bonding position.

於式(A21-3)所示的二價有機基團及式(A21-3')所示的二價有機基團中,苯環、聯苯結構、或萘環的一價取代基團例如為鹵素、碳數為1至10的烷基、碳數為2至10的烯基、碳數為1至10的烷氧基、碳數為1至10的氟烷基、碳數為2至10的氟烯基、碳數為1至10的氟烷氧基、羧基、羥基、碳數為1至10的烷氧基羰基、氰基,或硝基等。In the divalent organic group represented by formula (A21-3) and the divalent organic group represented by formula (A21-3'), the monovalent substituent group of the benzene ring, biphenyl structure, or naphthyl ring is, for example, a halogen, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluoroalkyl group having 1 to 10 carbon atoms, a fluoroalkenyl group having 2 to 10 carbon atoms, a fluoroalkoxy group having 1 to 10 carbon atoms, a carboxyl group, a hydroxyl group, an alkoxycarbonyl group having 1 to 10 carbon atoms, a cyano group, or a nitro group.

基於提高液晶配向性的觀點,較佳地,該式(A21-3)所示的二價有機基團為式(A21-3-1)至式(A21-3-16)所示的基團,其中「*」代表鍵結位置, 式(A21-3-1)、 式(A21-3-2)、 式(A21-3-3)、 式(A21-3-4)、 式(A21-3-5)、 式(A21-3-6)、 式(A21-3-7)、 式(A21-3-8)、 式(A21-3-9)、 式(A21-3-10)、 式(A21-3-11)、 式(A21-3-12)、 式(A21-3-13)、 式(A21-3-14)、 式(A21-3-15)、 式(A21-3-16)。 From the viewpoint of improving the liquid crystal alignment, preferably, the divalent organic group represented by formula (A21-3) is a group represented by formula (A21-3-1) to formula (A21-3-16), wherein "*" represents a bonding position, Formula (A21-3-1), Formula (A21-3-2), Formula (A21-3-3), Formula (A21-3-4), Formula (A21-3-5), Formula (A21-3-6), Formula (A21-3-7), Formula (A21-3-8), Formula (A21-3-9), Formula (A21-3-10), Formula (A21-3-11), Formula (A21-3-12), Formula (A21-3-13), Formula (A21-3-14), Formula (A21-3-15), Formula (A21-3-16).

在式(A21-3-1)中,m為0至1,且n為1至6。在式(A21-3-2)中,n為1至6。於式(A21-3-3)中,n為2至6。於式(A21-3-4)中,n為1至6。於式(A21-3-5)中,n為1至6。於式(A21-3-6)中,n為2至6。於式(A21-3-7)中,n為1至6。於式(A21-3-8)中,n為1至6。於式(A21-3-9)中,n為2至6。於式(A21-3-10)中,m為1至3,且n為1至4。於式(A21-3-11)中,n為1至6。於式(A21-3-12)中,n為1至6。於式(A21-3-13)中,m為0至1,且n為1至6。於式(A21-3-14)中,m為1至3,且n為1至4。In formula (A21-3-1), m is 0 to 1, and n is 1 to 6. In formula (A21-3-2), n is 1 to 6. In formula (A21-3-3), n is 2 to 6. In formula (A21-3-4), n is 1 to 6. In formula (A21-3-5), n is 1 to 6. In formula (A21-3-6), n is 2 to 6. In formula (A21-3-7), n is 1 to 6. In formula (A21-3-8), n is 1 to 6. In formula (A21-3-9), n is 2 to 6. In formula (A21-3-10), m is 1 to 3, and n is 1 to 4. In formula (A21-3-11), n is 1 to 6. In formula (A21-3-12), n is 1 to 6. In formula (A21-3-13), m is 0 to 1, and n is 1 to 6. In formula (A21-3-14), m is 1 to 3, and n is 1 to 4.

基於提高液晶配向性的觀點,較佳地,該式(A21-3')所示的二價有機基團為式(A21-3-7)至式(A21-3-16)所示的基團。From the viewpoint of improving the liquid crystal alignment, preferably, the divalent organic group represented by formula (A21-3') is a group represented by formula (A21-3-7) to formula (A21-3-16).

當該二胺化合物(b1-1)包含複數式(A21-1)所示的二胺化合物時,較佳地,式(A21-1)中的Y 31表示式(A21-3-1)至式(A21-3-14)的二胺化合物與式(A21-1)中的Y 31表示式(A21-3-15)至式(A21-3-16)的二胺化合物的組合。 When the diamine compound (b1-1) contains a diamine compound represented by a plurality of formulas (A21-1), preferably, Y 31 in formula (A21-1) represents a diamine compound of formula (A21-3-1) to formula (A21-3-14) and Y 31 in formula (A21-1) represents a combination of diamine compounds of formula (A21-3-15) to formula (A21-3-16).

在本發明的一些實施態樣中,該式(A21-2)所示的二胺化合物例如但不限於式(A21-2-1)至式(A21-2-5)所示的二胺化合物, 式 (A21-2-1)、 式 (A21-2-2)、 式 (A21-2-3)、 式(A21-2-4)、 式(A21-2-5)。 In some embodiments of the present invention, the diamine compound represented by formula (A21-2) is, for example but not limited to, the diamine compounds represented by formula (A21-2-1) to formula (A21-2-5), Formula (A21-2-1), Formula (A21-2-2), Formula (A21-2-3), Formula (A21-2-4), Formula (A21-2-5).

於式(A21-2-1)中,m為1至6,且n為1至6。於式(A21-2-2)中,m為1至6,且n為1至6。於式(A21-2-3)中,m為2至6,且n為2至6。In formula (A21-2-1), m is 1 to 6, and n is 1 to 6. In formula (A21-2-2), m is 1 to 6, and n is 1 to 6. In formula (A21-2-3), m is 2 to 6, and n is 2 to 6.

該二胺化合物(b1-1)可單獨一種使用或混合複數種使用。在本發明的一些實施態樣中,基於該二胺組份(b1)的總量為100莫耳,該二胺化合物(b1-1)的使用量為20莫耳至90莫耳,較佳地,為25莫耳至80莫耳,更佳地,為30莫耳至70莫耳。The diamine compound (b1-1) can be used alone or in combination. In some embodiments of the present invention, based on the total amount of the diamine component (b1) being 100 mol, the amount of the diamine compound (b1-1) used is 20 mol to 90 mol, preferably 25 mol to 80 mol, and more preferably 30 mol to 70 mol.

在本發明的一些實施態樣中,該二胺組份(b1)還包含具有-N(D)-的基團的二胺化合物(b1-2)。In some embodiments of the present invention, the diamine component (b1) further comprises a diamine compound (b1-2) having a -N(D)- group.

基於提高液晶配向膜的配向性的觀點,該第一聚合物(A1)的分子結構可選擇性地具有-N(D)-的基團(其中,D代表胺甲酸酯系保護基)。具有-N(D)-的基團的第一聚合物(A1)可藉由將具有-N(D)-的基團的單體作為反應原料的至少一部分之方法,或者藉由將具有-N(D)-的基團的單體作為下述封端劑的方法來獲得。在一些具體例中,該具有-N(D)-的基團的單體例如為具有-N(D)-的基團的二胺化合物(b1-2)。舉例而言,該胺甲酸酯系保護基例如但不限於第三丁氧基羰基(簡稱Boc)或9-茀基甲氧基羰基等。From the viewpoint of improving the alignment of the liquid crystal alignment film, the molecular structure of the first polymer (A1) may selectively have an -N(D)- group (wherein D represents a carbamate-based protective group). The first polymer (A1) having an -N(D)- group can be obtained by using a monomer having an -N(D)- group as at least a part of the reaction raw material, or by using a monomer having an -N(D)- group as the following end-capping agent. In some specific examples, the monomer having an -N(D)- group is, for example, a diamine compound (b1-2) having an -N(D)- group. For example, the carbamate-based protective group is, for example, but not limited to, tert-butyloxycarbonyl (Boc for short) or 9-fluorenylmethoxycarbonyl.

較佳地,該具有-N(D)-的基團的二胺化合物(b1-2)包含具有至少一個芳香基(例如苯環)的二胺化合物。更佳地,具有-N(D)-基團的二胺化合物(b1-2)包含具有至少一個芳香基且取代基(D)以外的殘基為碳數為6至30的二胺化合物。在一些具體例中,該具有-N(D)-基團的二胺化合物(b1-2)例如但不限於式(A22-1)至式(A22-10)所示的二胺化合物, 式(A22-1)、 式(A22-2)、 式(A22-3)、 式(A22-4)、 式(A22-5)、 式(A22-6)、 式(A22-7)、 式(A22-8)、 式(A22-9)、 式(A22-10)。 Preferably, the diamine compound (b1-2) having a -N(D)- group includes a diamine compound having at least one aromatic group (e.g., a benzene ring). More preferably, the diamine compound (b1-2) having a -N(D)- group includes a diamine compound having at least one aromatic group and a residue other than the substituent (D) having a carbon number of 6 to 30. In some specific examples, the diamine compound (b1-2) having a -N(D)- group is, for example, but not limited to, a diamine compound represented by formula (A22-1) to formula (A22-10), Formula (A22-1), Formula (A22-2), Formula (A22-3), Formula (A22-4), Formula (A22-5), Formula (A22-6), Formula (A22-7), Formula (A22-8), Formula (A22-9), Formula (A22-10).

於式(A22-1)中,n為1至6。於式(A22-2)中,n為1至6。於式(A22-4)中,m為1至6,且n為1至6。於式(A22-7)中,m為1至6,且n為1至6。於式(A22-9)中,n為1至6。In formula (A22-1), n is 1 to 6. In formula (A22-2), n is 1 to 6. In formula (A22-4), m is 1 to 6, and n is 1 to 6. In formula (A22-7), m is 1 to 6, and n is 1 to 6. In formula (A22-9), n is 1 to 6.

該具有-N(D)-的基團的二胺化合物(b1-2)可單獨一種使用或混合複數種使用。在本發明的一些實施態樣中,基於該二胺組份(b1)的總量為100莫耳,該具有-N(D)-的基團的二胺化合物(b1-2)的使用量為2莫耳至60莫耳,較佳地,為10莫耳至50莫耳,更佳地,為15莫耳至40莫耳。The diamine compound (b1-2) having a group of -N(D)- can be used alone or in combination. In some embodiments of the present invention, based on the total amount of the diamine component (b1) being 100 mol, the amount of the diamine compound (b1-2) having a group of -N(D)- is 2 mol to 60 mol, preferably 10 mol to 50 mol, and more preferably 15 mol to 40 mol.

在本發明的一些實施態樣中,該二胺組份(b1)還包含其他二胺化合物(b1-3)。In some embodiments of the present invention, the diamine component (b1) further comprises other diamine compounds (b1-3).

該其他二胺化合物(b1-3)例如但不限於具有光配向性基的二胺化合物、2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚、具有羧基的二胺化合物、3,3'-二胺基二苯基甲烷、4,4'-二胺基二苯基甲烷、3,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基酮、1,4-雙(4-胺基苄基)苯、4,4'-二胺基二苯醚、1-(4-胺基苯基)-1,3,3-三甲基-1H-二氫茚-5-胺、1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺、具有脲鍵的二胺化合物、具有醯胺鍵的二胺化合物、末端有光聚合性基的二胺化合物、具有矽氧烷鍵的二胺化合物,或具㗁唑啉結構的二胺化合物等。The other diamine compounds (b1-3) include, but are not limited to, diamine compounds having a photoalignment group, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, diamine compounds having a carboxyl group, 3,3'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylketone, 1,4- Bis(4-aminobenzyl)benzene, 4,4'-diaminodiphenyl ether, 1-(4-aminophenyl)-1,3,3-trimethyl-1H-dihydroindene-5-amine, 1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-indene-6-amine, a diamine compound having a urea bond, a diamine compound having an amide bond, a diamine compound having a photopolymerizable group at the end, a diamine compound having a siloxane bond, or a diamine compound having an oxazoline structure, etc.

該具有光配向性基的二胺化合物例如但不限於4,4'-二胺基偶氮苯,或式(A23-1)至式(A23-3)所示的二胺化合物等, 式(A23-1)、 式(A23-2)、 式(A23-3)。 The diamine compound having a photo-alignment group is, for example but not limited to, 4,4'-diaminoazobenzene, or diamine compounds represented by formula (A23-1) to formula (A23-3), Formula (A23-1), Formula (A23-2), Formula (A23-3).

該具有羧基的二胺化合物例如但不限於2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸,或式(A23-4)至式(A23-7)所示的二胺化合物等, 式(A23-4)、 式(A23-5)、 式(A23-6)、 式(A23-7)。 The diamine compound having a carboxyl group is, for example but not limited to, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid, or diamine compounds represented by formula (A23-4) to formula (A23-7), Formula (A23-4), Formula (A23-5), Formula (A23-6), Formula (A23-7).

於式(A23-4)中,Y 51表示單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-;m1及m2分別獨立地表示0至4的整數,且(m1+m2)表示1至4的整數。於式(A23-5)中,m3及m4分別獨立地表示1至5的整數。於式(A23-6)中,Y 52表示碳數為1至5的直鏈或支鏈烷基;m5表示1至5的整數。於式(A24-7)中,Y 53及Y 54分別獨立地表示單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-;m6表示1至4的整數。 In formula (A23-4), Y51 represents a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2- , -C( CF3 ) 2- , -O-, -CO-, -NH-, -N ( CH3 )-, -CONH-, -NHCO-, -CH2O- , -OCH2- , -COO-, -OCO-, -CON( CH3 )- or -N( CH3 )CO-; m1 and m2 each independently represent an integer from 0 to 4, and (m1+m2) represents an integer from 1 to 4. In formula (A23-5), m3 and m4 each independently represent an integer from 1 to 5. In formula (A23-6), Y52 represents a linear or branched alkyl group having 1 to 5 carbon atoms; m5 represents an integer from 1 to 5. In formula (A24-7) , Y53 and Y54 each independently represent a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2-, -C( CF3 ) 2- , -O-, -CO- , -NH-, -N ( CH3 )-, -CONH-, -NHCO-, -CH2O-, -OCH2- , -COO-, -OCO-, -CON( CH3 )- or -N( CH3 )CO-; m6 represents an integer from 1 to 4.

該具有脲鍵的二胺化合物例如但不限於式(A23-8)至式(A23-10)所示的二胺化合物等, 式(A23-8)、 式(A23-9)、 式(A23-10)。 The diamine compound having a urea bond is, for example but not limited to, the diamine compounds represented by formula (A23-8) to formula (A23-10), Formula (A23-8), Formula (A23-9), Formula (A23-10).

於式(A23-8)中,n1為0至6,且n2為1至6。於式(A23-9)中,n1為1至6,且n2為1至6。於式(A23-10)中,n為1至6。In formula (A23-8), n1 is 0 to 6, and n2 is 1 to 6. In formula (A23-9), n1 is 1 to 6, and n2 is 1 to 6. In formula (A23-10), n is 1 to 6.

該具有醯胺鍵的二胺化合物例如但不限於式(A23-11)至式(A23-13)所示的具有醯胺鍵的二胺化合物, 式(A23-11)、 式(A23-12)、 式(A23-13)。 The diamine compound having an amide bond is, for example but not limited to, the diamine compound having an amide bond represented by formula (A23-11) to formula (A23-13), Formula (A23-11), Formula (A23-12), Formula (A23-13).

於式(A23-12)中,n為1至6。於式(A23-13)中,n1為1至6,且n2為1至6。In formula (A23-12), n is 1 to 6. In formula (A23-13), n1 is 1 to 6, and n2 is 1 to 6.

該末端有光聚合性基的二胺化合物例如但不限於甲基丙烯酸2-(2,4-二胺基苯氧基)乙基,或2,4-二胺基-N,N-二烯丙基苯胺等。The diamine compound having a photopolymerizable group at the end thereof may be, for example but not limited to, 2-(2,4-diaminophenoxy)ethyl methacrylate or 2,4-diamino-N,N-diallylaniline.

該具有矽氧烷鍵的二胺化合物例如但不限於3-雙(3-胺基丙基)-四甲基二矽氧烷。The diamine compound having a siloxane bond is, for example but not limited to, 3-bis(3-aminopropyl)-tetramethyldisiloxane.

該具㗁唑啉結構的二胺化合物例如但不限於式(A23-14)至式(A23-15)所示的二胺化合物等, 式(A23-14)、 式(A23-15)。 The diamine compound having an oxazoline structure is, for example but not limited to, the diamine compounds represented by formula (A23-14) to formula (A23-15), Formula (A23-14), Formula (A23-15).

該其他二胺化合物(b1-3)可單獨一種使用或混合複數種使用。在本發明的一些實施態樣中,基於該二胺組份(b1)的總量為100莫耳,該其他二胺化合物(b1-3)的使用量為0莫耳至65莫耳,較佳地,為0莫耳至50莫耳,更佳地,為0莫耳至35莫耳。The other diamine compound (b1-3) can be used alone or in combination. In some embodiments of the present invention, based on the total amount of the diamine component (b1) being 100 mol, the amount of the other diamine compound (b1-3) is 0 mol to 65 mol, preferably 0 mol to 50 mol, and more preferably 0 mol to 35 mol.

為使包含由本發明液晶配向劑所形成的液晶配向膜的液晶顯示元件具有更不易閃爍的優點,較佳地,在本發明的一些實施態樣中,基於該聚合物組份(A)的總使用量為100重量份,該第一聚合物(A1)的使用量為5重量份至85重量份。更佳地,為10重量份至80重量份,又更佳地,為10重量份至75重量份。In order to make the liquid crystal display device including the liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention have the advantage of being less prone to flicker, preferably, in some embodiments of the present invention, based on the total usage of the polymer component (A) being 100 parts by weight, the usage of the first polymer (A1) is 5 parts by weight to 85 parts by weight. More preferably, it is 10 parts by weight to 80 parts by weight, and even more preferably, it is 10 parts by weight to 75 parts by weight.

第二聚合物Second polymer (A2)>(A2)>

在本發明的一些實施態樣中,該聚合物組份(A)還包括第二聚合物(A2)。In some embodiments of the present invention, the polymer component (A) further comprises a second polymer (A2).

該第二聚合物(A2)選自於由包含四羧酸二酐組份(a2)及二胺組份(b2)的反應組成物經反應所形成的聚醯亞胺前驅物及由該聚醯亞胺前驅物所形成的醯亞胺化聚合物所組成的群組中的至少一者,其中,該第二聚合物(A2)的四羧酸二酐組份(a2)不包含該第一聚合物(A1)的四羧酸二酐組份(a1)中的四羧酸二酐混合物(a1-1)。舉例而言,該第二聚合物(A2)為具有聚醯胺酸及聚醯胺酸酯的醯亞胺前驅物結構的聚醯亞胺前驅物,或者,該第二聚合物(A2)為該聚醯亞胺前驅物所形成的醯亞胺化聚合物(即聚醯亞胺),或者,該第二聚合物(A2)包含該聚醯亞胺前驅物及該醯亞胺化聚合物。該第二聚合物(A2)可單獨一種使用,也可混合複數種使用。The second polymer (A2) is selected from at least one of the group consisting of a polyimide precursor formed by reacting a reaction composition comprising a tetracarboxylic dianhydride component (a2) and a diamine component (b2) and an imidized polymer formed by the polyimide precursor, wherein the tetracarboxylic dianhydride component (a2) of the second polymer (A2) does not contain the tetracarboxylic dianhydride mixture (a1-1) in the tetracarboxylic dianhydride component (a1) of the first polymer (A1). For example, the second polymer (A2) is a polyimide precursor having an imide precursor structure of polyamic acid and polyamic acid ester, or the second polymer (A2) is an imidized polymer (i.e., polyimide) formed by the polyimide precursor, or the second polymer (A2) includes the polyimide precursor and the imidized polymer. The second polymer (A2) can be used alone or in combination of a plurality of types.

四羧酸二酐組份Tetracarboxylic dianhydride component (a2)>(a2)>

該四羧酸二酐組份(a2)例如但不限於非環脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物、芳香族四羧酸二酐化合物,或這些化合物的衍生物。該四羧酸二酐組份(a2)可單獨一種使用或混合複數種使用。The tetracarboxylic dianhydride component (a2) includes, but is not limited to, acyclic aliphatic tetracarboxylic dianhydride compounds, alicyclic tetracarboxylic dianhydride compounds, aromatic tetracarboxylic dianhydride compounds, or derivatives thereof. The tetracarboxylic dianhydride component (a2) may be used alone or in combination of a plurality of types.

該非環脂肪族四羧酸二酐可例如係將鍵結於鏈狀烴結構的四個羧基進行分子內脫水所獲得的酸二酐。惟,非環脂肪族四羧酸二酐無須僅由鏈狀烴結構所構成,其一部分也可具有脂環族結構或芳香環結構。The acyclic aliphatic tetracarboxylic dianhydride may be, for example, an acid dianhydride obtained by intramolecular dehydration of four carboxyl groups bonded to a chain hydrocarbon structure. However, the acyclic aliphatic tetracarboxylic dianhydride does not need to be composed only of a chain hydrocarbon structure, and a portion thereof may have an alicyclic structure or an aromatic ring structure.

該脂環族四羧酸二酐例如將包含鍵結於脂環族結構之至少一個羧基在內而將四個羧基進行分子內脫水所獲得的酸二酐。惟,此四個羧基均未鍵結於芳香環。或者,可無須僅由脂環族結構所構成,其一部分也可具有鏈狀烴結構或芳香環結構。The alicyclic tetracarboxylic dianhydride may be, for example, an acid dianhydride obtained by intramolecular dehydration of four carboxyl groups including at least one carboxyl group bonded to an alicyclic structure. However, none of the four carboxyl groups is bonded to an aromatic ring. Alternatively, it is not necessary to be composed of only an alicyclic structure, and a part of it may have a chain hydrocarbon structure or an aromatic ring structure.

該芳香族四羧酸二酐例如將包含鍵結於芳香環之至少一個羧基在內的四個羧基進行分子內脫水所獲得的酸二酐。惟,芳香族四羧酸二酐無須僅由芳香環結構所構成,其一部分也可具有鏈狀烴結構或脂環族結構。The aromatic tetracarboxylic dianhydride is, for example, an acid dianhydride obtained by intramolecular dehydration of four carboxyl groups including at least one carboxyl group bonded to an aromatic ring. However, the aromatic tetracarboxylic dianhydride does not need to be composed only of an aromatic ring structure, and a portion thereof may have a chain hydrocarbon structure or an alicyclic structure.

較佳地,該四羧酸二酐組份(a2)包含如上式(A11)所示且X 1'代表式(A11-1)至式(A11-6)所示的結構的四羧酸二酐化合物或其衍生物。 Preferably, the tetracarboxylic dianhydride component (a2) comprises a tetracarboxylic dianhydride compound or a derivative thereof as shown in the above formula (A11) and X 1′ represents a structure shown in formula (A11-1) to formula (A11-6).

較佳地,該四羧酸二酐組份(a2)包含式(A11)所示且X 1'為式(III)所示的結構的四羧酸二酐化合物(a2-1), 式(III)。 Preferably, the tetracarboxylic dianhydride component (a2) comprises a tetracarboxylic dianhydride compound (a2-1) having a structure represented by formula (A11) and X 1' having a structure represented by formula (III). Formula (III).

在式(III)中,Z 11表示單鍵,且「*」代表鍵結位置。 In formula (III), Z 11 represents a single bond, and “*” represents a bonding position.

該四羧酸二酐化合物(a2-1)可單獨一種使用或混合複數種使用。The tetracarboxylic dianhydride compound (a2-1) may be used alone or in combination of two or more.

更佳地,該四羧酸二酐組份(a2)包含式(IV)所示的四羧酸二酐化合物, 式(IV)。 More preferably, the tetracarboxylic dianhydride component (a2) comprises a tetracarboxylic dianhydride compound represented by formula (IV), Formula (IV).

在本發明的一些實施態樣中,基於該四羧酸二酐組份(a2)的總量為100莫耳,該四羧酸二酐化合物(a2-1)的使用量為30莫耳至100莫耳,較佳地,為40莫耳至100莫耳,更佳地,為50莫耳至100莫耳。In some embodiments of the present invention, based on the total amount of the tetracarboxylic dianhydride component (a2) being 100 mol, the amount of the tetracarboxylic dianhydride compound (a2-1) used is 30 mol to 100 mol, preferably 40 mol to 100 mol, and more preferably 50 mol to 100 mol.

二胺組份Diamine component (b2)>(b2)>

該二胺組份(b2)例如但不限於該第一聚合物(A1)的二胺組份(b1),或者,具有含氮原子結構的二胺化合物(b2-1)。該二胺組份(b2)可單獨一種使用或混合複數種使用。The diamine component (b2) is, for example but not limited to, the diamine component (b1) of the first polymer (A1), or a diamine compound (b2-1) having a nitrogen atom-containing structure. The diamine component (b2) can be used alone or in combination of two or more.

具有含氮原子結構的二胺化合物Diamine compound having a nitrogen atom-containing structure (b2-1)>(b2-1)>

該具有含氮原子結構的二胺化合物(b2-1)中的含氮原子結構選自於由含氮原子的雜環、二級胺基及三級胺基所構成的群組中的至少一種。The nitrogen-containing structure in the diamine compound (b2-1) having a nitrogen-containing structure is at least one selected from the group consisting of a nitrogen-containing heterocyclic group, a diamine group, and a tertiary amine group.

該具有含氮原子結構的二胺化合物(b2-1)的含氮原子的雜環例如但不限於吡咯、咪唑、吡唑、三唑、吡啶、嘧啶、嗒𠯤、吡𠯤、吲哚、苯并咪唑、嘌呤、喹啉、異喹啉、㖠啶、喹㗁啉、呔𠯤、三𠯤、咔唑、吖啶、哌啶、哌𠯤、吡咯啶或六亞甲基亞胺等。較佳地,該含氮原子的雜環為吡啶、嘧啶、吡𠯤、哌啶、哌𠯤、喹啉、咔唑或吖啶。The nitrogen-containing heterocyclic ring of the diamine compound (b2-1) having a nitrogen-containing structure is, for example but not limited to, pyrrole, imidazole, pyrazole, triazole, pyridine, pyrimidine, pyrimidine, pyrimidine, pyrimidine, indole, benzimidazole, purine, quinoline, isoquinoline, oxadiazole, quinoline, pyrimidine, tririmidine, carbazole, acridine, piperidine, piperidine, pyrrolidine or hexamethyleneimine, etc. Preferably, the nitrogen-containing heterocyclic ring is pyridine, pyrimidine, pyrimidine, piperidine, piperidine, quinoline, carbazole or acridine.

該具有含氮原子結構的二胺化合物(b2-1)中的含氮原子結構為式(B21)所示的二級胺基及三級胺基, 式(B21)。 The nitrogen-containing atom structure in the diamine compound (b2-1) having a nitrogen-containing atom structure is a diamine group and a tertiary amine group represented by formula (B21), Formula (B21).

於式(B21)中,Z表示氫、碳數為1至10的烷基、環烷基或芳基;「*」代表鍵結位置。In formula (B21), Z represents hydrogen, an alkyl group having 1 to 10 carbon atoms, a cycloalkyl group, or an aryl group; "*" represents a bonding position.

該碳數為1至10的烷基例如但不限於甲基、乙基或丙基。該環烷基例如但不限於環己基。該芳基例如但不限於苯基或甲苯基。較佳地,Z為氫或甲基。The alkyl group with a carbon number of 1 to 10 is, for example, but not limited to, methyl, ethyl or propyl. The cycloalkyl group is, for example, but not limited to, cyclohexyl. The aryl group is, for example, but not limited to, phenyl or tolyl. Preferably, Z is hydrogen or methyl.

該具有含氮原子結構的二胺化合物(b2-1)例如但不限於2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)-哌𠯤、3,6-二胺基吖啶、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、式(B21-1)至式(B21-8)所示的二胺化合物,或式(B21-9)至式(B21-26)所示的二胺化合物, 式(B21-1)、 式(B21-2)、 式(B21-3)、 式(B21-4)、 式(B21-5)、 式(B21-6)、 式(B21-7)、 式(B21-8)、 式(B21-9)、 式(B21-10)、 式(B21-11)、 式(B21-12)、 式(B21-13)、 式(B21-14)、 式(B21-15)、 式(B21-16)、 式(B21-17)、 式(B21-18)、 式(B21-19)、 式(B21-20)、 式(B21-21)、 式(B21-22)、 式(B21-23)、 式(B21-24)、 式(B21-25)、 式(B21-26)。 The diamine compound (b2-1) having a nitrogen atom-containing structure is, for example but not limited to, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 1,4-bis-(4-aminophenyl)-piperidinium, 3,6-diaminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, diamine compounds represented by formula (B21-1) to (B21-8), or diamine compounds represented by formula (B21-9) to (B21-26), Formula (B21-1), Formula (B21-2), Formula (B21-3), Formula (B21-4), Formula (B21-5), Formula (B21-6), Formula (B21-7), Formula (B21-8), Formula (B21-9), Formula (B21-10), Formula (B21-11), Formula (B21-12), Formula (B21-13), Formula (B21-14), Formula (B21-15), Formula (B21-16), Formula (B21-17), Formula (B21-18), Formula (B21-19), Formula (B21-20), Formula (B21-21), Formula (B21-22), Formula (B21-23), Formula (B21-24), Formula (B21-25), Formula (B21-26).

於式(B21-5)中,n表示1至4。於式(B21-6)中,n表示1至4。該具有含氮原子結構的二胺化合物(b2-1)可單獨一種使用或混合複數種使用。In formula (B21-5), n represents 1 to 4. In formula (B21-6), n represents 1 to 4. The diamine compound (b2-1) having a nitrogen atom-containing structure may be used alone or in combination of two or more.

當該二胺組份(b2)包含該具有含氮原子結構的二胺化合物(b2-1)時,包含由該液晶配向劑所形成的液晶配向膜的液晶顯示元件具有更低的驅動後亮度變化率。When the diamine component (b2) includes the diamine compound (b2-1) having a structure containing nitrogen atoms, a liquid crystal display device including a liquid crystal alignment film formed by the liquid crystal alignment agent has a lower brightness change rate after driving.

在本發明的一些實施態樣中,基於該二胺組份(b2)的總量為100莫耳,該具有含氮原子結構的二胺化合物(b2-1)的使用量為15莫耳至100莫耳,較佳地,為20莫耳至90莫耳,更佳地,為25莫耳至80莫耳。In some embodiments of the present invention, based on the total amount of the diamine component (b2) being 100 mol, the usage amount of the diamine compound (b2-1) having a nitrogen atom-containing structure is 15 mol to 100 mol, preferably 20 mol to 90 mol, and more preferably 25 mol to 80 mol.

為使包含由本發明液晶配向劑所形成的液晶配向膜的液晶顯示元件具有更不易閃爍的優點,較佳地,在本發明的一些實施態樣中,基於該聚合物組份(A)的總使用量為100重量份,該第二聚合物(A2)的使用量為15重量份至95重量份,更佳地,為20重量份至90重量份,又更佳地,為25重量份至90重量份。In order to make the liquid crystal display element including the liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention have the advantage of being less prone to flicker, preferably, in some embodiments of the present invention, based on the total usage of the polymer component (A) being 100 parts by weight, the usage of the second polymer (A2) is 15 to 95 parts by weight, more preferably, 20 to 90 parts by weight, and even more preferably, 25 to 90 parts by weight.

在本發明的一些實施態樣中,基於該聚合物組份(A)的總使用量為100重量份,該第一聚合物(A1)的使用量為5至90重量份,而該第二聚合物(A2)的使用量為10至95重量份。In some embodiments of the present invention, based on 100 parts by weight of the total usage of the polymer component (A), the usage of the first polymer (A1) is 5 to 90 parts by weight, and the usage of the second polymer (A2) is 10 to 95 parts by weight.

<第一聚合物(A1)及第二聚合物(A2)的製備方法><Method for preparing the first polymer (A1) and the second polymer (A2)>

該第一聚合物(A1)及該第二聚合物(A2)的製造可藉由使上述的二胺組份和四羧酸二酐組份於溶劑中進行(縮聚合)反應來進行。當該第一聚合物(A1)及該第二聚合物(A2)的一部分具有醯胺酸結構時,例如藉由使四羧酸二酐組份與二胺組份反應,以獲得具有醯胺酸結構的聚合物(即聚醯胺酸)。該溶劑沒有特別的限制,僅須可溶解所形成的聚合物即可。舉例而言,該溶劑例如但不限於N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸或1,3-二甲基-2-咪唑啶酮等。在本發明的一些實施態樣中,當聚合物的溶劑溶解性較高時,該溶劑例如甲乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮,或如式(D-1)至式(D-3)所示的溶劑, 式(D-1)、 式(D-2)、 式(D-3)。 The first polymer (A1) and the second polymer (A2) can be produced by reacting the above-mentioned diamine component and tetracarboxylic dianhydride component in a solvent (polycondensation). When a portion of the first polymer (A1) and the second polymer (A2) has an acylamidic acid structure, for example, the tetracarboxylic dianhydride component is reacted with the diamine component to obtain a polymer having an acylamidic acid structure (i.e., polyacylamidic acid). The solvent is not particularly limited, and only needs to be able to dissolve the formed polymer. For example, the solvent is, for example, but not limited to, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or 1,3-dimethyl-2-imidazolidinone. In some embodiments of the present invention, when the solvent solubility of the polymer is high, the solvent is, for example, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, or a solvent as shown in formula (D-1) to formula (D-3), Formula (D-1), Formula (D-2), Formula (D-3).

於式(D-1)中,Z 1表示碳數為1至3的烷基。於式(D-2)中,Z 2表示碳數為1至3的烷基。於式(D-3)中,Z 3表示碳數為1至4的烷基。 In formula (D-1), Z 1 represents an alkyl group having 1 to 3 carbon atoms. In formula (D-2), Z 2 represents an alkyl group having 1 to 3 carbon atoms. In formula (D-3), Z 3 represents an alkyl group having 1 to 4 carbon atoms.

該溶劑可單獨一種使用,或混合複數種使用。其次,縱使是無法溶解聚合物的溶劑,該無法溶解聚合物的溶劑仍可在所生成的聚合物不會析出的範圍內,與上述的溶劑混合使用。當二胺組份與四羧酸二酐組份在溶劑中反應時,反應能以任意的濃度來進行,較佳地,該反應的濃度為1wt%至50wt%,更佳地,為5wt%至30wt%。反應初始亦可於高濃度進行,然後,額外添加溶劑。進行反應時,較佳地,二胺組份的總莫耳數與四羧酸二酐組份的總莫耳數的比值為0.8至1.2。相同於一般的縮聚反應,二胺組份的總莫耳數與四羧酸二酐組份的總莫耳數的比越接近1.0時,所形成的第一聚合物(A1)或第二聚合物(A2)的分子量越大。The solvent can be used alone or in combination. Secondly, even if the solvent is insoluble in the polymer, the solvent can be mixed with the above-mentioned solvent within the range that the generated polymer will not precipitate. When the diamine component and the tetracarboxylic dianhydride component react in the solvent, the reaction can be carried out at any concentration. Preferably, the concentration of the reaction is 1wt% to 50wt%, and more preferably, 5wt% to 30wt%. The reaction can also be carried out at a high concentration initially, and then the solvent is added additionally. When the reaction is carried out, preferably, the ratio of the total molar number of the diamine component to the total molar number of the tetracarboxylic dianhydride component is 0.8 to 1.2. Similar to a general polycondensation reaction, the closer the ratio of the total molar number of the diamine component to the total molar number of the tetracarboxylic dianhydride component is to 1.0, the larger the molecular weight of the first polymer (A1) or the second polymer (A2) formed.

具有醯胺酸酯結構的聚合物可例如藉由習知方法來獲得,且該習知方法為(1)使上述方法所獲得的聚醯胺酸與酯化劑反應的方法、(2)使四羧酸二酯化合物與二胺化合物進行反應的方法,或(3)使四羧酸二酯二鹵化物與二胺化合物進行反應的方法。The polymer having an acylamidoester structure can be obtained, for example, by a known method, and the known method is (1) a method of reacting the polyacylamidoester obtained by the above method with an esterifying agent, (2) a method of reacting a tetracarboxylic acid diester compound with a diamine compound, or (3) a method of reacting a tetracarboxylic acid diester dihalide with a diamine compound.

本發明液晶配向劑的第一聚合物(A1)或第二聚合物(A2)中的醯亞胺化聚合物可例如藉由將該具有醯胺酸酯結構的聚合物予以閉環來獲得。於該醯亞胺化聚合物中,醯胺酸基或其衍生物所具有的官能基的閉環率(亦稱為醯亞胺化率)不一定須為100%,該醯亞胺化聚合物的醯亞胺化率可根據用途及/或目的任意調整。The imidized polymer in the first polymer (A1) or the second polymer (A2) of the liquid crystal alignment agent of the present invention can be obtained, for example, by ring-closing the polymer having an acylamidate structure. In the imidized polymer, the ring-closing ratio (also called the imidization ratio) of the functional group possessed by the acylamidate group or its derivative is not necessarily 100%, and the imidization ratio of the imidized polymer can be arbitrarily adjusted according to the use and/or purpose.

對於獲得醯亞胺化聚合物的方法,例如為將包含具有醯胺酸酯結構的聚合物的溶液直接加熱的熱醯亞胺化,或者於該溶液添加觸媒的觸媒醯亞胺化。於該溶液中進行熱醯亞胺化時,較佳地,溫度為100℃至400℃,更佳地,為120℃至250℃。於進行熱醯亞胺化時,較佳地,一併將醯亞胺化反應所生成的水排除到系統外。The method for obtaining the imidized polymer includes, for example, directly heating a solution containing a polymer having an amide structure for thermal imidization, or adding a catalyst to the solution for catalytic imidization. When thermal imidization is performed in the solution, preferably, the temperature is 100° C. to 400° C., more preferably, 120° C. to 250° C. When thermal imidization is performed, preferably, water generated by the imidization reaction is discharged out of the system.

該觸媒醯亞胺化例如為於該溶液中添加鹼性觸媒及酸酐來進行,較佳地,於-20℃至250℃進行攪拌,更佳地,於0℃至180℃。較佳地,該鹼性觸媒的添加量為醯胺酸基的莫耳當量的0.5倍至30倍,更佳地,為2倍至20倍。較佳地,該酸酐的添加量為醯胺酸基的莫耳當量的1倍至50倍,更佳地,為3倍至30倍。該鹼性觸媒例如但不限於吡啶、三乙胺、三甲胺、三丁胺或三辛胺等。其中,由於吡啶具有使反應進行的適度鹼性,故較理想。該酸酐例如但不限於乙酸酐、偏苯三甲酸酐或苯均四酸酐等。其中,當使用乙酸酐,反應結束後的純化較容易,故較理想。觸媒醯亞胺化的醯亞胺化率可藉由調整觸媒量、反應溫度及/或反應時間來控制。The catalytic imidization is carried out, for example, by adding an alkaline catalyst and an acid anhydride to the solution, preferably, stirring is carried out at -20°C to 250°C, more preferably, at 0°C to 180°C. Preferably, the amount of the alkaline catalyst added is 0.5 to 30 times the molar equivalent of the amide group, more preferably, 2 to 20 times. Preferably, the amount of the acid anhydride added is 1 to 50 times the molar equivalent of the amide group, more preferably, 3 to 30 times. The alkaline catalyst is, for example, but not limited to, pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine. Among them, pyridine is ideal because it has a moderate alkalinity that allows the reaction to proceed. The acid anhydride is, for example, but not limited to, acetic anhydride, trimellitic anhydride, or pyromellitic anhydride. Among them, when acetic anhydride is used, purification after the reaction is easier, so it is more ideal. The imidization rate of the catalytic imidization can be controlled by adjusting the amount of catalyst, reaction temperature and/or reaction time.

當從上述醯亞胺化的反應溶液回收所形成的醯亞胺化聚合物時,將反應溶液投入到溶劑並使其沉澱即可。沉澱使用的溶劑例如但不限於甲醇、乙醇、異丙醇、丙酮、己烷、丁基賽珞蘇(butyl cellosolve)、庚烷、甲乙酮、甲基異丁基酮、甲苯、苯或水等。過濾並回收投入至溶劑所沉澱的聚合物後,可於常壓或減壓下,常溫或加熱乾燥。或者,將沉澱回收的聚合物溶於溶劑,並進行再沉澱回收,此操作重複進行2次至10次,可減少聚合物中的雜質。所使用的溶劑可例如為醇類或酮類烴等。若使用於其中所選出的三種以上的溶劑,精製的效率可進一步提高,故較理想。When the imidized polymer is recovered from the imidized reaction solution, the reaction solution is put into a solvent and precipitated. The solvent used for precipitation is, for example, but not limited to, methanol, ethanol, isopropanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene or water. After filtering and recovering the polymer precipitated in the solvent, it can be dried at normal pressure or reduced pressure, at room temperature or by heating. Alternatively, the polymer recovered by precipitation is dissolved in a solvent and reprecipitated and recovered. This operation is repeated 2 to 10 times to reduce impurities in the polymer. The solvent used can be, for example, alcohols or ketones. If more than three selected solvents are used, the efficiency of purification can be further improved, which is more ideal.

於配置成濃度為10wt%至15wt%的溶液時,本發明第一聚合物(A1)或第二聚合物(A2)的溶液黏度沒有特別的限制,基於較易操作的觀點,溶液黏度可例如為10mPa・s至1000mPa・s。聚合物的溶液黏度(mPa・s)是使用該聚合物的良溶劑(例如:γ-丁內酯或N-甲基-2-吡咯烷酮等)配製成濃度為10wt%至15wt%的聚合物溶液,並使用E型旋轉黏度計於25℃所測得的數值。When the solution is prepared into a concentration of 10wt% to 15wt%, the solution viscosity of the first polymer (A1) or the second polymer (A2) of the present invention is not particularly limited. Based on the viewpoint of easier operation, the solution viscosity can be, for example, 10mPa·s to 1000mPa·s. The solution viscosity (mPa·s) of the polymer is a value measured at 25°C using a good solvent for the polymer (e.g., γ-butyrolactone or N-methyl-2-pyrrolidone, etc.) to prepare a polymer solution with a concentration of 10wt% to 15wt%.

較佳地,本發明第一聚合物(A1)或第二聚合物(A2)利用凝膠滲透層析(GPC)所測得以聚苯乙烯換算的重量平均分子量(Mw)為1,000至500,000,更佳地,為2,000至500,000。其次,較佳地,Mw與利用GPC所測得以聚苯乙烯換算的數量平均分子量(Mn)的比值所表示的分子量分布(Mw/Mn)為15以下,更佳地,為10以下。當聚合物的分子量為上述的分子量範圍時,可確保液晶顯示元件的良好配向性及安定性。Preferably, the weight average molecular weight (Mw) of the first polymer (A1) or the second polymer (A2) of the present invention measured by gel permeation chromatography (GPC) in terms of polystyrene is 1,000 to 500,000, more preferably, 2,000 to 500,000. Secondly, preferably, the molecular weight distribution (Mw/Mn) represented by the ratio of Mw to the number average molecular weight (Mn) measured by GPC in terms of polystyrene is 15 or less, more preferably, 10 or less. When the molecular weight of the polymer is within the above molecular weight range, good orientation and stability of the liquid crystal display element can be ensured.

當合成本發明第一聚合物(A1)或第二聚合物(A2)時,可使用如上述的四羧酸二酐組份及二胺組份,且併用適當的封端劑來合成末端密封型的聚合物。末端密封型的聚合物具有可提升利用塗膜所獲得的液晶配向膜的膜硬度,以及提升密封劑及液晶配向膜的密合特性的效果。本發明第一聚合物(A1)或第二聚合物(A2)的末端可例如胺基、羧基、酸酐基或該等的衍生物。胺基、羧基、酸酐基或該等的衍生物可藉由一般的縮合反應來獲得,或者藉由使用下述的封端劑來密封末端所獲得。相同地,上述的衍生物可例如使用下述的封端劑來獲得。When synthesizing the first polymer (A1) or the second polymer (A2) of the present invention, the tetracarboxylic dianhydride component and the diamine component as described above can be used, and a suitable end-capping agent can be used to synthesize an end-sealed polymer. The end-sealed polymer has the effect of improving the film hardness of the liquid crystal alignment film obtained by coating, and improving the sealing properties of the sealant and the liquid crystal alignment film. The end of the first polymer (A1) or the second polymer (A2) of the present invention can be, for example, an amine group, a carboxyl group, an anhydride group, or a derivative thereof. The amine group, the carboxyl group, the anhydride group, or a derivative thereof can be obtained by a general condensation reaction, or by using the following end-capping agent to seal the end. Similarly, the above-mentioned derivatives can be obtained, for example, using the following end-capping agent.

該封端劑例如但不限於酸酐、二碳酸二酯化合物、氯羰基化合物、單元胺化合物或單異氰酸酯化合物等。該酸酐例如但不限於乙酸酐、馬來酸酐、奈地酸酐、鄰苯二甲酸酐、衣康酸酐、環己烷二羧酸酐、3-羥基鄰苯二甲酸酐、偏苯三甲酸酐、3-((3-三甲氧基矽基)丙基)-3,4-二氫呋喃-2,5-二酮、4,5,6,7-四氟異苯并呋喃-1,3-二酮或4-乙炔基鄰苯二甲酸酐。該二碳酸二酯化合物例如但不限於二碳酸二第三丁酯或二碳酸二烯丙酯等。該氯羰基化合物例如但不限於丙烯醯氯、甲基丙烯醯氯或菸鹼醯氯等。該單元胺化合物例如但不限於苯胺、2-胺基苯酚、3-胺基苯酚、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、環己胺、正丁胺、正戊胺、正己胺、正庚胺或正辛胺等。該單異氰酸酯化合物例如但不限於乙基異氰酸酯、苯基異氰酸酯或萘基異氰酸酯等。The end-capping agent may be, for example, but not limited to, an acid anhydride, a dicarbonic acid diester compound, a chlorocarbonyl compound, a monoamine compound, or a monoisocyanate compound. The acid anhydride may be, for example, but not limited to, acetic anhydride, maleic anhydride, neddic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3-((3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione, or 4-ethynylphthalic anhydride. The dicarbonic acid diester compound may be, for example, but not limited to, di-tert-butyl dicarbonate or diallyl dicarbonate. The chlorocarbonyl compound may be, for example, but not limited to, acryloyl chloride, methacryloyl chloride, or nicotinyl chloride. The monoamine compound includes, but is not limited to, aniline, 2-aminophenol, 3-aminophenol, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, or n-octylamine. The monoisocyanate compound includes, but is not limited to, ethyl isocyanate, phenyl isocyanate, or naphthyl isocyanate.

該封端劑可單獨一種使用或混合複數種使用。在本發明的一些實施態樣中,較佳地,基於該二胺組份的總量為100莫耳份,該封端劑的使用量為0.01莫耳份至20莫耳份,更佳地,為0.01莫耳份至10莫耳份。The end-capping agent can be used alone or in combination. In some embodiments of the present invention, preferably, based on the total amount of the diamine component being 100 moles, the end-capping agent is used in an amount of 0.01 to 20 moles, more preferably, 0.01 to 10 moles.

本發明液晶配向劑的聚合物組份(A)可選擇性地還包含其他聚合物。該其他聚合物例如但不限於聚酯、聚醯胺、聚脲、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯或其衍生物、聚(苯乙烯-苯基馬來醯亞胺)衍生物,或聚(甲基)丙烯酸酯等。The polymer component (A) of the liquid crystal alignment agent of the present invention may optionally further include other polymers, such as but not limited to polyester, polyamide, polyurea, polyorganosiloxane, cellulose derivative, polyacetal, polystyrene or its derivative, poly(styrene-phenylmaleimide) derivative, or poly(meth)acrylate.

[[ 溶劑Solvent (B)](B)]

基於形成均勻薄膜的觀點,液晶配向劑採取塗佈液的形態,以製作液晶配向膜。較佳地,本發明液晶配向劑為含有聚合物組份(A)及溶劑(B)的塗佈液。其中,基於所設定的欲形成的塗膜厚度,液晶配向劑中的聚合物組份(A)的濃度可適當改變。基於形成均勻且無缺陷的塗膜的觀點,較佳地,液晶配向劑中的聚合物組份(A)的濃度為1wt%以上。基於溶液的保存安定性的觀點,較佳地,液晶配向劑中的聚合物組份(A)的濃度為10wt%以下。理想的聚合物組份(A)的濃度為2wt%至8wt%。液晶配向劑中的聚合物組份(A)的含量可藉由液晶配向劑的塗佈方法及/或所欲液晶配向膜的膜厚來適當改變,較佳地,為2wt%至10wt%,更佳地,為3wt%至8wt%。From the perspective of forming a uniform film, the liquid crystal alignment agent takes the form of a coating liquid to produce a liquid crystal alignment film. Preferably, the liquid crystal alignment agent of the present invention is a coating liquid containing a polymer component (A) and a solvent (B). Among them, based on the set coating thickness to be formed, the concentration of the polymer component (A) in the liquid crystal alignment agent can be appropriately changed. From the perspective of forming a uniform and defect-free coating, preferably, the concentration of the polymer component (A) in the liquid crystal alignment agent is greater than 1wt%. From the perspective of the storage stability of the solution, preferably, the concentration of the polymer component (A) in the liquid crystal alignment agent is less than 10wt%. The ideal concentration of the polymer component (A) is 2wt% to 8wt%. The content of the polymer component (A) in the liquid crystal alignment agent can be appropriately changed by the coating method of the liquid crystal alignment agent and/or the film thickness of the desired liquid crystal alignment film, preferably, it is 2wt% to 10wt%, more preferably, it is 3wt% to 8wt%.

液晶配向劑中的溶劑(B)例如有機溶劑,且該溶劑(B)沒有特別的限制,僅須可將聚合物組份(A)均勻溶解即可。該溶劑(B)例如但不限於N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基乳醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、γ-戊內酯、1,3-二甲基-2-咪唑啶酮、甲乙酮、環己酮、環戊酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、N-(正丙基)-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-(正丁基)-2-吡咯烷酮、N-(第三丁基)-2-吡咯烷酮、N-(正戊基)-2-吡咯烷酮、N-甲氧基丙基-2-吡咯烷酮、N-乙氧基乙基-2-吡咯烷酮、N-甲氧基丁基-2-吡咯烷酮或N-環己基-2-吡咯烷酮等,而上述的溶劑亦稱為良溶劑。其中,N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺或γ-丁內酯為較佳。在本發明的一些實施態樣中,基於液晶配向劑中溶劑(B)的總量為100wt%,良溶劑的使用量為20wt%至99wt%,較佳地,為20wt%至90wt%,更佳地,為30wt%至80wt%。The solvent (B) in the liquid crystal alignment agent is, for example, an organic solvent, and the solvent (B) is not particularly limited, as long as it can evenly dissolve the polymer component (A). The solvent (B) is, for example, but not limited to, N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide , N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone or N-cyclohexyl-2-pyrrolidone, etc., and the above solvents are also called good solvents. Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide or γ-butyrolactone is preferred. In some embodiments of the present invention, based on the total amount of the solvent (B) in the liquid crystal alignment agent being 100 wt %, the amount of the good solvent used is 20 wt % to 99 wt %, preferably 20 wt % to 90 wt %, and more preferably 30 wt % to 80 wt %.

其次,較佳地,液晶配向劑中的溶劑(B)包含上述良溶劑,以及可提升液晶配向劑塗佈時的塗佈性與塗膜的表面平滑性的貧溶劑。較佳地,基於液晶配向劑中的溶劑(B)的總量為100wt%,該貧溶劑的使用量為1wt%至80wt%,更佳地,為10wt%至80wt%,尤佳地,為20wt%至70wt%。該貧溶劑的種類及使用量可依據液晶配向劑的塗佈裝置、塗佈條件及/或塗佈環境等適當選擇。Secondly, preferably, the solvent (B) in the liquid crystal alignment agent includes the above-mentioned good solvent and a poor solvent that can improve the coating property of the liquid crystal alignment agent and the surface smoothness of the coating film. Preferably, based on the total amount of the solvent (B) in the liquid crystal alignment agent being 100wt%, the usage amount of the poor solvent is 1wt% to 80wt%, more preferably, 10wt% to 80wt%, and even more preferably, 20wt% to 70wt%. The type and usage amount of the poor solvent can be appropriately selected according to the coating device, coating conditions and/or coating environment of the liquid crystal alignment agent.

該貧溶劑例如但不限於二異丙醚、二異丁醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、4-羥基-4-甲基-2-戊酮、二乙二醇甲基乙醚、二乙二醇二丁醚、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸伸丙酯、碳酸伸乙酯、乙二醇單丁醚(丁基賽珞蘇)、乙二醇單異戊醚、乙二醇單己醚、丙二醇單丁醚、1-(2-丁氧基乙氧基)-2-丙醇、2-(2-丁氧基乙氧基)-1-丙醇、丙二醇單甲醚乙酸酯、丙二醇二乙酸酯、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、乙二醇單丁醚乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、丙二醇二乙酸酯、乙酸正丁酯、乙酸丙二醇單乙醚、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸正丁酯、乳酸異戊酯、二乙二醇單乙醚,或二異丁基酮(2,6-二甲基-4-庚酮)等。The poor solvent includes, but is not limited to, diisopropyl ether, diisobutyl ether, diisobutyl carbinol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol methyl ethyl ether, diethylene glycol dibutyl ether, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, ethylene glycol monoacetate, ethylene glycol diacetate, propylene carbonate, ethyl carbonate, ethylene glycol monobutyl ether (butyl celoxylate), ethylene glycol monoisopentyl ether, ethylene glycol monohexyl ether, propylene glycol monobutyl ether, 1-(2-butoxyethoxy)- 2-propanol, 2-(2-butoxyethoxy)-1-propanol, propylene glycol monomethyl ether acetate, propylene glycol diacetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, propylene glycol diacetate, n-butyl acetate, propylene glycol monoethyl acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, propyl 3-methoxypropionate, butyl 3-methoxypropionate, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, or diisobutyl ketone (2,6-dimethyl-4-heptanone), etc.

較佳地,該貧溶劑為二異丁基甲醇、丙二醇單丁醚、丙二醇二乙酸酯、二乙二醇二乙醚、二丙二醇單甲醚、二丙二醇二甲醚、4-羥基-4-甲基-2-戊酮、乙二醇單丁醚、乙二醇單丁醚乙酸酯,或二異丁基酮等。Preferably, the poor solvent is diisobutyl carbinol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, or diisobutyl ketone.

較佳地,良溶劑與貧溶劑的溶劑組合例如但不限於N-甲基-2-吡咯烷酮與乙二醇單丁醚;N-甲基-2-吡咯烷酮、γ-丁內酯與乙二醇單丁醚;N-甲基-2-吡咯烷酮、γ-丁內酯與丙二醇單丁醚;N-乙基-2-吡咯烷酮與丙二醇單丁醚;N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮;N-乙基-2-吡咯烷酮與丙二醇二乙酸酯;N,N-二甲基乳醯胺與二異丁基酮;N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯;N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯;N-甲基-2-吡咯烷酮與乙二醇單丁醚乙酸酯;N-乙基-2-吡咯烷酮與二丙二醇二甲醚;N,N-二甲基乳醯胺與乙二醇單丁醚;N,N-二甲基乳醯胺與丙二醇二乙酸酯;N-乙基-2-吡咯烷酮與二乙二醇二乙醚;N,N-二甲基乳醯胺與二乙二醇二乙醚;N-甲基-2-吡咯烷酮、γ-丁內酯、4-羥基-4-甲基-2-戊酮與二乙二醇二乙醚;N-乙基-2-吡咯烷酮、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮;N-乙基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇單丁醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與二異丁基酮;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與二丙二醇單甲醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇單丁醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯;γ-丁內酯、4-羥基-4-甲基-2-戊酮與二異丁基酮;γ-丁內酯、4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯;N-甲基-2-吡咯烷酮、γ-丁內酯、丙二醇單丁醚與二異丁基酮;N-甲基-2-吡咯烷酮、γ-丁內酯與丙二醇單丁醚與二異丙醚;N-甲基-2-吡咯烷酮、γ-丁內酯、丙二醇單丁醚與二異丁基甲醇;N-甲基-2-吡咯烷酮、γ-丁內酯與二丙二醇二甲醚;N-甲基-2-吡咯烷酮、丙二醇單丁醚與二丙二醇二甲醚;N-乙基-2-吡咯烷酮、丙二醇單丁醚與二丙二醇單甲醚;N-乙基-2-吡咯烷酮、丙二醇單丁醚與丙二醇二乙酸酯;N-乙基-2-吡咯烷酮、丙二醇單丁醚與二異丁基酮;N-乙基-2-吡咯烷酮、γ-丁內酯與二異丁基酮;或者N-乙基-2-吡咯烷酮、N,N-二甲基乳醯胺與二異丁基酮等。Preferably, the solvent combination of good solvent and poor solvent is, for example, but not limited to, N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone and ethylene glycol monobutyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol monobutyl ether; N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether; N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone; N-ethyl-2-pyrrolidone and propylene glycol diacetate; N,N-dimethyl lactamide and diisobutyl ketone; N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate; N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate; N-methyl-2-pyrrolidone and ethyl Glycol monobutyl ether acetate; N-ethyl-2-pyrrolidone and dipropylene glycol dimethyl ether; N,N-dimethyl lactamide and ethylene glycol monobutyl ether; N,N-dimethyl lactamide and propylene glycol diacetate; N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether; N,N-dimethyl lactamide and diethylene glycol diethyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and diethylene glycol diethyl ether; N-ethyl-2-pyrrolidone, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone; N-ethyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether; N-methyl-2-pyrrolidone, 4-Hydroxy-4-methyl-2-pentanone and diisobutyl ketone; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol monomethyl ether; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate; γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and diisobutyl ketone; γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate; N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether and diisobutyl ketone; N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol diacetate Glycol monobutyl ether and diisopropyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether and diisobutyl carbinol; N-methyl-2-pyrrolidone, γ-butyrolactone and dipropylene glycol dimethyl ether; N-methyl-2-pyrrolidone, propylene glycol monobutyl ether and dipropylene glycol dimethyl ether; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and dipropylene glycol monomethyl ether; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and propylene glycol diacetate; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and diisobutyl ketone; N-ethyl-2-pyrrolidone, γ-butyrolactone and diisobutyl ketone; or N-ethyl-2-pyrrolidone, N,N-dimethyllactamide and diisobutyl ketone, etc.

該溶劑(B)可單獨一種使用或混合複數種使用。在本發明的一些實施態樣中,基於該聚合物組份(A)的總量為100重量份,該溶劑(B)的使用量為800重量份至3000重量份,較佳地,為900重量份至2800重量份,更佳地,為1000重量份至2500重量份。The solvent (B) can be used alone or in combination. In some embodiments of the present invention, based on the total amount of the polymer component (A) being 100 parts by weight, the amount of the solvent (B) used is 800 to 3000 parts by weight, preferably 900 to 2800 parts by weight, and more preferably 1000 to 2500 parts by weight.

本發明液晶配向劑還包含添加劑。該添加劑例如但不限於用以提高液晶配向膜與基板的密合性或液晶配向膜與密封劑的密合性的密合助劑、用以提高液晶配向膜的強度的交聯性化合物、用以促進醯亞胺化的化合物、用以調整液晶配向膜的介電常數或電阻的介電體或導電物質等。The liquid crystal alignment agent of the present invention further includes additives, such as but not limited to adhesion aids for improving the adhesion between the liquid crystal alignment film and the substrate or between the liquid crystal alignment film and the sealant, cross-linking compounds for improving the strength of the liquid crystal alignment film, compounds for promoting imidization, dielectrics or conductive substances for adjusting the dielectric constant or resistance of the liquid crystal alignment film, etc.

該密合助劑例如但不限於3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽基丙基三伸乙基三胺、N-三甲氧基矽基丙基三伸乙基三胺、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參(3-三甲氧基矽基丙基)異氰尿酸酯,或3-異氰酸酯丙基三乙氧基矽烷等矽烷偶合劑。使用密合助劑時,基於對於AC殘影展現良好耐性的觀點,較佳地,相對於液晶配向劑中聚合物組份(A)的總使用量為100重量份,密合助劑的使用量為0.1重量份至30重量份,更佳地,為0.1重量份至20重量份。The adhesion promoter is, for example but not limited to, 3-aminopropyl trimethoxysilane, 3-aminopropyl triethoxysilane, 3-aminopropyl diethoxymethyl silane, 2-aminopropyl trimethoxysilane, 2-aminopropyl triethoxysilane, N-(2-aminoethyl)-3-aminopropyl trimethoxysilane, N-(2-aminoethyl)-3-aminopropyl methyl dimethoxysilane, 3-ureidopropyl trimethoxysilane, 3-ureidopropyl triethoxysilane, N-ethoxycarbonyl-3-aminopropyl trimethoxysilane, N-ethoxycarbonyl-3-aminopropyl triethoxysilane, N-triethoxysilylpropyl triethyl triamine, N-trimethoxysilylpropyl triethyl triamine, vinyl trimethoxysilane, Silane, vinyl triethoxysilane, 2-(3,4-epoxyhexyl)ethyl trimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, 3-methacryloyloxypropylmethyldimethoxysilane Silane coupling agents such as methoxysilane, 3-methacryloxypropyl trimethoxysilane, 3-methacryloxypropyl methyldiethoxysilane, 3-methacryloxypropyl triethoxysilane, 3-acryloxypropyl trimethoxysilane, tris(3-trimethoxysilylpropyl) isocyanurate, or 3-isocyanatepropyl triethoxysilane. When a bonding aid is used, based on the viewpoint of exhibiting good resistance to AC afterimage, preferably, the amount of the bonding aid used is 0.1 to 30 parts by weight, more preferably, 0.1 to 20 parts by weight, relative to 100 parts by weight of the total amount of the polymer component (A) in the liquid crystal alignment agent.

基於對AC殘影展現良好耐性且有效改善膜強度的觀點,該交聯性化合物為具有環氧乙烷基、環氧丙烷基、選自於由式(E1)所示的基團及式(E2)所示的基團所組成的群組中的至少一種基團的化合物,或選自式(E3)所示的化合物中的化合物, 式(E1)、 式(E2)、 式(E3)。 From the viewpoint of exhibiting good resistance to AC afterimage and effectively improving film strength, the crosslinking compound is a compound having an ethylene oxide group, a propylene oxide group, at least one group selected from the group consisting of a group represented by formula (E1) and a group represented by formula (E2), or a compound selected from the compound represented by formula (E3), Formula (E1), Formula (E2), Formula (E3).

於式(E1)中,G 1及G 2各自獨立地表示氫、碳數為1至3的烷基或-CH 2-OH。於式(E2)中,G 3表示碳數為1至6的烷基、碳數為2至6的烯基或碳數為2至6的炔基。G 4表示氫、碳數為1至4的烷基、碳數為2至6的烯基或碳數為2至6的炔基。於式(E3)中,G 5表示含有芳香環的(g1+g2)價有機基團。G 6表示氫或碳數為1至5的烷基。g1表示1至6的整數,g2表示0至4的整數。 In formula (E1), G1 and G2 each independently represent hydrogen, an alkyl group having 1 to 3 carbon atoms, or -CH2 - OH. In formula (E2), G3 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or an alkynyl group having 2 to 6 carbon atoms. G4 represents hydrogen, an alkyl group having 1 to 4 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or an alkynyl group having 2 to 6 carbon atoms. In formula (E3), G5 represents a (g1+g2)-valent organic group containing an aromatic ring. G6 represents hydrogen or an alkyl group having 1 to 5 carbon atoms. g1 represents an integer from 1 to 6, and g2 represents an integer from 0 to 4.

於式(E3)中,G 5的具有芳香環的(g1+g2)價有機基團例如碳數為6至30的(g1+g2)價芳香族烴基、碳數為6至30的芳香族烴基直接或介隔連結基所鍵結形的(g1+g2)價有機基團,或具有芳香族雜環的(g1+g2)價基團。該芳香族烴例如為苯或萘等。該芳香族雜環例如上述的含氮原子結構的例示芳香族雜環。該連結基例如碳數為1至10的伸烷基或從該伸烷基取走一個氫原子的基團,或者二價或三價的環己烷等。其中,該伸烷基的任意氫也可被取代為氟原子或三氟甲基等有機基團。於式(E3)中,G 6所代表之碳數為1至5的烷基例如甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基或正戊基。 In formula (E3), the (g1+g2)-valent organic group having an aromatic ring of G5 is, for example, a (g1+g2)-valent aromatic hydrocarbon group having 6 to 30 carbon atoms, a (g1+g2)-valent organic group to which an aromatic hydrocarbon group having 6 to 30 carbon atoms is directly or via a linking group, or a (g1+g2)-valent group having an aromatic heterocyclic ring. The aromatic hydrocarbon is, for example, benzene or naphthalene. The aromatic heterocyclic ring is, for example, the exemplified aromatic heterocyclic ring of the nitrogen atom-containing structure described above. The linking group is, for example, an alkylene group having 1 to 10 carbon atoms or a group from which a hydrogen atom is removed, or a divalent or trivalent cyclohexane. Any hydrogen of the alkylene group may also be substituted with an organic group such as a fluorine atom or a trifluoromethyl group. In formula (E3), G6 represents an alkyl group having 1 to 5 carbon atoms, such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl or n-pentyl.

該具有環氧乙烷基的化合物例如但不限於N,N,N',N'-四環氧丙基間二甲苯二胺、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、N,N,N',N'-四環氧丙基-4,4'-二胺基二苯基甲烷、N,N,N',N'-四環氧丙基-對苯二胺,或式(E4)至式(E6)所示的含有氮化合物等, 式(E4)、 式(E5)、 式(E6)。 The compound having an ethylene oxide group is, for example but not limited to, N,N,N',N'-tetraethylene oxide propyl meta-xylene diamine, 1,3-bis(N,N-diethylene oxide propylaminomethyl)cyclohexane, N,N,N',N'-tetraethylene oxide propyl-4,4'-diaminodiphenylmethane, N,N,N',N'-tetraethylene oxide propyl-p-phenylenediamine, or nitrogen-containing compounds represented by formula (E4) to formula (E6), Formula (E4), Formula (E5), Formula (E6).

該具有環氧丙烷基的化合物例如但不限於式(E7)至式(E16)所示的化合物, 式(E7)、 式(E8)、 式(E9)、 式(E10)、 式(E11)、 式(E12)、 式(E13)、 式(E14)、 式(E15)、 式(E16)。 The compound having an propylene oxide group is, for example but not limited to, the compounds represented by formula (E7) to formula (E16), Formula (E7), Formula (E8), Formula (E9), Formula (E10), Formula (E11), Formula (E12), Formula (E13), Formula (E14), Formula (E15), Formula (E16).

於式(E1)中,n表示1至3。於式(E13)中,n表示1至3。於式(E14)中,n表示1至100。於式(E15)中,R代表 ,其中,「*」代表鍵結位置。於式(E16)中,n表示1至10。 In formula (E1), n represents 1 to 3. In formula (E13), n represents 1 to 3. In formula (E14), n represents 1 to 100. In formula (E15), R represents , wherein "*" represents a bonding position. In formula (E16), n represents 1 to 10.

該具有式(E1)所示基團的化合物例如但不限於式(E1-1)至式(E1-12)所示的化合物, 式(E1-1)、 式(E1-2)、 式(E1-3)、 式(E1-4)、 式(E1-5)、 式(E1-6)、 式(E1-7)、 式(E1-8)、 式(E1-9)、 式(E1-10)、 式(E1-11)、 式(E1-12)。 The compound having the group represented by formula (E1) includes, but is not limited to, compounds represented by formula (E1-1) to formula (E1-12), Formula (E1-1), Formula (E1-2), Formula (E1-3), Formula (E1-4), Formula (E1-5), Formula (E1-6), Formula (E1-7), Formula (E1-8), Formula (E1-9), Formula (E1-10), Formula (E1-11), Formula (E1-12).

該具有式(E2)所示基團的化合物例如但不限於式(E2-1)至式(E2-4)所示的化合物, 式(E2-1)、 式(E2-2)、 式(E2-3)、 式(E2-4)。 The compound having the group represented by formula (E2) is, for example but not limited to, the compounds represented by formula (E2-1) to formula (E2-4), Formula (E2-1), Formula (E2-2), Formula (E2-3), Formula (E2-4).

於式(E2-1)中,n表示2至16。於式(E2-2)中,n表示2至16。In formula (E2-1), n represents 2 to 16. In formula (E2-2), n represents 2 to 16.

該具有式(E3)所示基團的化合物例如但不限於式(E3-1)至式(E3-10)所示的化合物, 式(E3-1)、 式(E3-2)、 式(E3-3)、 式(E3-4)、 式(E3-5)、 式(E3-6)、 式(E3-7)、 式(E3-8)、 式(E3-9)、 式(E3-10)。 The compound having the group represented by formula (E3) is, for example but not limited to, the compounds represented by formula (E3-1) to formula (E3-10), Formula (E3-1), Formula (E3-2), Formula (E3-3), Formula (E3-4), Formula (E3-5), Formula (E3-6), Formula (E3-7), Formula (E3-8), Formula (E3-9), Formula (E3-10).

在本發明液晶配向劑中,較佳地,基於該液晶配向劑的聚合物組份(A)的總量為100重量份,該交聯性化合物的使用量為0.5重量份至20重量份。其中,基於交聯反應的進行與對於AC殘影展現良好耐性的觀點,更佳地,該交聯性化合物的使用量為1重量份至15重量份。In the liquid crystal alignment agent of the present invention, preferably, based on the total amount of the polymer component (A) of the liquid crystal alignment agent being 100 parts by weight, the amount of the crosslinking compound used is 0.5 to 20 parts by weight. In particular, based on the viewpoint of the crosslinking reaction and the good resistance to AC afterimage, more preferably, the amount of the crosslinking compound used is 1 to 15 parts by weight.

較佳地,上述用以促進醯亞胺化的化合物為具有鹼性部位(例如:一級胺基、脂肪族雜環(如吡咯啶骨架)、芳香族雜環(如咪唑環或吲哚環),或胍基等)的化合物(惟上述交聯性化合物及密合助劑除外),或者煅燒時會產生所述鹼性部位的化合物。更佳地,促進醯亞胺化的化合物為煅燒時會產生該鹼性部位的化合物,例如胺基酸所具有的鹼性部位的一部分或全部係被保護的胺基酸。該胺基酸例如甘胺酸、丙胺酸、半胱胺酸、甲硫胺酸、天冬醯胺、麩醯胺酸、纈胺酸、白胺酸、苯丙胺酸、酪胺酸、色胺酸、脯胺酸、羥基脯胺酸、精胺酸、組胺酸、離胺酸,或鳥胺酸。基於促進醯亞胺化的化合物的目的,更佳地,具體例可列舉為N-α-(9-茀基甲氧基羰基)-N-τ-(第三丁氧基羰基)-L-組胺酸。Preferably, the compound for promoting imidization is a compound having a basic site (e.g., a primary amine group, an aliphatic heterocycle (e.g., a pyrrolidine skeleton), an aromatic heterocycle (e.g., an imidazole ring or an indole ring), or a guanidine group, etc.) (excluding the crosslinking compound and the adhesion promoter), or a compound that generates the basic site when calcined. More preferably, the compound for promoting imidization is a compound that generates the basic site when calcined, for example, an amino acid having a part or all of the basic site of the amino acid being protected. The amino acid is, for example, glycine, alanine, cysteine, methionine, asparagine, glutamine, valine, leucine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline, arginine, histidine, lysine, or ornithine. For the purpose of promoting the amidation compound, more preferably, a specific example can be N-α-(9-fluorenylmethoxycarbonyl)-N-τ-(tert-butyloxycarbonyl)-L-histidine.

<液晶配向膜及液晶顯示元件><Liquid crystal alignment film and liquid crystal display element>

本發明液晶配向膜是由上述液晶配向劑所形成。本發明液晶配向膜可作為IPS的水平配向型液晶顯示元件的液晶配向膜。本發明液晶顯示元件包含該液晶配向膜。本發明液晶顯示元件可例如藉由步驟(1)至步驟(4)的方法來製作,或,步驟(1)至步驟(2)與步驟(4)的方法來製作。The liquid crystal alignment film of the present invention is formed by the above-mentioned liquid crystal alignment agent. The liquid crystal alignment film of the present invention can be used as a liquid crystal alignment film of a horizontal alignment type liquid crystal display element of IPS. The liquid crystal display element of the present invention includes the liquid crystal alignment film. The liquid crystal display element of the present invention can be manufactured, for example, by the method of steps (1) to (4), or by the method of steps (1) to (2) and step (4).

步驟(1):將液晶配向劑塗佈於基板上Step (1): Apply liquid crystal alignment agent on the substrate

利用如輥塗法、旋塗法、印刷法或噴墨法等適當的塗佈方法,在設有經圖案化的透明導電膜的基板的一面上塗佈本發明的液晶配向劑。其中,基板沒有特別的限制,僅須為高透明性的基板即可,也可將玻璃基板或氮化矽基板與壓克力基板或聚碳酸酯基板等塑膠基板併用。其次,於反射型的液晶顯示元件中,當僅是單側的基板,也能使用矽晶圓等不透明物,且所使用的電極也可為鋁等可反射光的材料。再者,製作IPS型的液晶顯示元件時,梳齒型係使用已設置經圖案化的透明導電膜或金屬膜所構成的電極基板及未設置電極的對向基板。The liquid crystal alignment agent of the present invention is applied on one side of a substrate having a patterned transparent conductive film by using an appropriate coating method such as roller coating, spin coating, printing or inkjet. There is no particular limitation on the substrate, as long as it is a highly transparent substrate. A glass substrate or a silicon nitride substrate may be used together with a plastic substrate such as an acrylic substrate or a polycarbonate substrate. Secondly, in a reflective liquid crystal display element, when only a single-sided substrate is used, an opaque material such as a silicon wafer may be used, and the electrode used may be a light-reflecting material such as aluminum. Furthermore, when manufacturing an IPS-type liquid crystal display element, a comb-tooth type uses an electrode substrate having a patterned transparent conductive film or metal film and an opposing substrate having no electrode.

將該液晶配向劑塗佈於基板並成膜的方法可列舉網版印刷、平版印刷、柔版印刷、噴墨法或噴塗法等。較佳地,該成膜方法是利用噴墨法的塗佈。The method of coating the liquid crystal alignment agent on the substrate and forming a film can be screen printing, lithography, flexographic printing, inkjet method or inkjet coating method, etc. Preferably, the film forming method is coating using the inkjet method.

步驟(2):煅燒所塗佈的液晶配向劑Step (2): calcining the coated liquid crystal alignment agent

步驟(2)是煅燒已塗佈於基板上的液晶配向劑,以形成膜的步驟。將液晶配向劑塗佈於基板上後,可利用熱板、熱循環型烘箱或紅外線型烘箱等加熱手段使溶劑蒸發,或進行聚醯胺酸或聚醯胺酸酯的熱醯亞胺化。已塗佈本發明的液晶配向劑後所進行的乾燥與煅燒步驟可選擇任意的溫度及時間,且可進行多次乾燥或煅燒步驟。乾燥溫度可例如為40℃至180℃。基於縮短處理的觀點,可於40℃至150℃下進行。乾燥時間沒有特別限定,其可例如為1分鐘至10分鐘或1分鐘至5分鐘。進行聚醯胺酸或聚醯胺酸酯的熱醯亞胺化時,在上述的乾燥步驟後,可進一步於例如150℃至300℃或150℃至250℃的溫度下進行煅燒步驟。煅燒時間沒有特別的限定,例如5分鐘至40分鐘或5分鐘至30分鐘。當煅燒後的膜狀物太薄,則液晶顯示元件的可靠性會降低,因此,較佳地,膜狀物厚度為5nm至300nm,更佳地,為10nm至200nm。Step (2) is a step of calcining the liquid crystal alignment agent coated on the substrate to form a film. After the liquid crystal alignment agent is coated on the substrate, the solvent can be evaporated by heating means such as a hot plate, a heat circulation oven or an infrared oven, or thermal imidization of polyamine or polyamine ester can be performed. The drying and calcining steps after the liquid crystal alignment agent of the present invention has been coated can be selected at any temperature and time, and multiple drying or calcining steps can be performed. The drying temperature can be, for example, 40°C to 180°C. From the perspective of shortening the process, it can be carried out at 40°C to 150°C. There is no particular limitation on the drying time, and it may be, for example, 1 minute to 10 minutes or 1 minute to 5 minutes. When thermal imidization of polyamine acid or polyamine ester is performed, after the above-mentioned drying step, a calcination step may be further performed at a temperature of, for example, 150°C to 300°C or 150°C to 250°C. There is no particular limitation on the calcination time, and it may be, for example, 5 minutes to 40 minutes or 5 minutes to 30 minutes. When the film after calcination is too thin, the reliability of the liquid crystal display element will be reduced. Therefore, preferably, the film thickness is 5nm to 300nm, and more preferably, 10nm to 200nm.

步驟(3):對步驟(2)所獲得的膜進行配向處理Step (3): Performing an alignment treatment on the film obtained in step (2)

步驟(3)是視情形對步驟(2)所獲得的膜進行配向處理。也就是說,於IPS的水平配向型的液晶顯示元件中,對該塗膜實施配向處理,以賦予配向能力。該配向處理為光配向處理。該光配向處理可列舉於上述膜狀物的表面照射已沿一定方向偏向的放射線,並視情形,較佳地,為以150℃至250℃的溫度加熱,以賦予液晶配向性(也稱為液晶配向能力)的方法。放射線可使用波長為100nm至800nm的紫外線或可見光線。較佳地,放射線為波長為100nm至400nm的紫外線,更佳地,為200nm至400nm的紫外線。Step (3) is to perform an alignment treatment on the film obtained in step (2) as appropriate. That is, in the horizontal alignment type liquid crystal display element of IPS, the coating film is subjected to an alignment treatment to impart alignment ability. The alignment treatment is a photo-alignment treatment. The photo-alignment treatment can be exemplified by irradiating the surface of the above-mentioned film-like object with radiation that has been deflected in a certain direction, and as appropriate, preferably, heating at a temperature of 150°C to 250°C to impart liquid crystal alignment (also referred to as liquid crystal alignment ability). The radiation can use ultraviolet light or visible light with a wavelength of 100nm to 800nm. Preferably, the radiation is ultraviolet light with a wavelength of 100nm to 400nm, and more preferably, ultraviolet light with a wavelength of 200nm to 400nm.

放射線的照射量可為1mJ/cm 2至10,000mJ/cm 2,較佳地,為100mJ/cm 2至5,000mJ/cm 2,更佳地,為100mJ/cm 2至1500mJ/cm 2,尤佳地,為100mJ/cm 2至1000mJ/cm 2。使用一般液晶配向劑時,配向處理的光照射量為100mJ/cm 2至5000mJ/cm 2,但本發明液晶配向劑,即使配向處理的光照射量減少,仍可形成膜面內的液晶配向性的變異(不均勻性)有效被抑制的液晶配向膜。於照射放射線時,為了改善液晶配向性,具有該膜狀物的基板可於照射同時,以50℃至250℃進行加熱。依此方式所製作的液晶配向膜可使液晶分子按一定的方向穩定配向。其次,上述方法中已照射經偏光的放射線的液晶配向膜可使用溶劑進行接觸處理,或者將已照射放射線的液晶配向膜進行加熱處理。 The radiation exposure amount may be 1mJ/ cm2 to 10,000mJ/ cm2 , preferably 100mJ/ cm2 to 5,000mJ/ cm2 , more preferably 100mJ/ cm2 to 1500mJ/ cm2 , and particularly preferably 100mJ/ cm2 to 1000mJ/ cm2 . When a general liquid crystal alignment agent is used, the light exposure amount for the alignment treatment is 100mJ/ cm2 to 5000mJ/ cm2 , but the liquid crystal alignment agent of the present invention can still form a liquid crystal alignment film in which the variation (unevenness) of the liquid crystal alignment in the film surface is effectively suppressed even if the light exposure amount for the alignment treatment is reduced. When irradiating radiation, in order to improve the liquid crystal alignment, the substrate with the film-like object can be heated at 50°C to 250°C while irradiating. The liquid crystal alignment film produced in this way can make the liquid crystal molecules stably align in a certain direction. Secondly, the liquid crystal alignment film irradiated with polarized radiation in the above method can be contact-treated with a solvent, or the liquid crystal alignment film irradiated with radiation can be heated.

上述接觸處理所使用的溶劑沒有特別的限制,僅須可溶解經放射線照射後,從膜狀物所生成的分解物即可。該溶劑例如水、甲醇、乙醇、2-丙醇、丙酮、甲乙酮、1-甲氧基-2-丙醇、1-甲氧基-2-丙醇乙酸酯、丁基賽珞蘇、乳酸乙酯、乳酸甲酯、二丙酮醇、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙酸丙酯、乙酸丁酯,或乙酸環己酯等。其中,基於泛用性與安全性的觀點,較佳地,該溶劑為水、2-丙醇、1-甲氧基-2-丙醇或乳酸乙酯,更佳地,為水、1-甲氧基-2-丙醇或乳酸乙酯。該溶劑可單獨一種使用或混合複數種使用。The solvent used in the above-mentioned contact treatment is not particularly limited, and it only needs to be able to dissolve the decomposition products generated from the film after irradiation. The solvent is, for example, water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl celoxylate, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, or cyclohexyl acetate. Among them, based on the viewpoint of versatility and safety, it is preferred that the solvent is water, 2-propanol, 1-methoxy-2-propanol or ethyl lactate, and more preferably, it is water, 1-methoxy-2-propanol or ethyl lactate. The solvent can be used alone or in combination.

較佳地,對上述已照射放射線的塗膜進行加熱處理的溫度為50℃至300℃,更佳地,為120℃至250℃。較佳地,加熱處理的時間為1分鐘至30分鐘。Preferably, the temperature of the heat treatment of the coating film irradiated with radiation is 50° C. to 300° C., more preferably, 120° C. to 250° C. Preferably, the heat treatment time is 1 minute to 30 minutes.

步驟(4):製作液晶胞Step (4): Making liquid crystal cells

準備兩片前述所形成的液晶配向膜基板,並於面向配置的兩片基板間配置液晶。舉例而言,可列舉下述的兩種方法。第一種方法,首先以各液晶配向膜面對的方式,隔著間隙(晶胞間隙)將兩片基板面向配置。然後,將兩片基板的周邊部以密封劑貼合,再將液晶組成物注入填充至由基板表面及密封劑區隔出的晶胞間隙內,並於其接觸膜面後,密封注入孔。Prepare two substrates with the liquid crystal alignment films formed above, and arrange the liquid crystal between the two substrates facing each other. For example, the following two methods can be listed. The first method is to arrange the two substrates facing each other with a gap (cell gap) between them in a way that the liquid crystal alignment films face each other. Then, the periphery of the two substrates is bonded with a sealant, and then the liquid crystal composition is injected into the cell gap separated by the substrate surface and the sealant, and after it contacts the film surface, the injection hole is sealed.

第二種方法稱為ODF(液晶滴入式封填;One Drop Fill)方法。在已形成液晶配向膜的兩片基板中的其中一者的預定位置塗佈如紫外光硬化性的密封劑,然後,於液晶配向膜面上的多個預定位置滴加液晶組成物。然後,以液晶配向膜相面對的方式貼合另一基板,而將液晶組成物推壓在基板的整面,使其接觸膜面。接著,對基板整面照射紫外光,以使密封劑硬化。依進行上述任一方法時,較佳地,進一步將所使用的液晶組成物加熱至成為等向相的溫度,然後,緩慢放冷到室溫,以去除液晶填充時的流動配向。其次,對塗膜實施摩擦處理時,兩片基板係以各塗膜的摩擦方向互相成預定角度來面向配置,例如成直交或反向平行的方式。密封劑可例如為含有硬化劑及作為間隔件的氧化鋁球的環氧樹脂等。液晶組成物例如向列型液晶或層列型液晶,較佳地,為向列型液晶。The second method is called ODF (One Drop Fill) method. A sealant such as a UV-curable sealant is applied to a predetermined position of one of the two substrates on which a liquid crystal alignment film has been formed, and then a liquid crystal composition is dripped onto a plurality of predetermined positions on the surface of the liquid crystal alignment film. Then, the other substrate is bonded with the liquid crystal alignment films facing each other, and the liquid crystal composition is pushed onto the entire surface of the substrate so that it contacts the film surface. Then, ultraviolet light is irradiated onto the entire surface of the substrate to cure the sealant. When any of the above methods is performed, it is preferred that the liquid crystal composition used is further heated to a temperature at which it becomes an isotropic phase, and then slowly cooled to room temperature to remove the flow alignment during liquid crystal filling. Secondly, when the coating is subjected to friction treatment, the two substrates are arranged to face each other with the friction directions of each coating forming a predetermined angle with each other, such as being orthogonal or antiparallel. The sealant may be, for example, epoxy resin containing a hardener and aluminum oxide balls as spacers. The liquid crystal composition may be, for example, nematic liquid crystal or lamellar liquid crystal, preferably, nematic liquid crystal.

視需要可於液晶胞的外側表面貼合偏光板,以獲得液晶顯示元件。液晶胞的外表面所貼合的偏光板例如延伸配向聚乙烯醇並同時吸收碘,且稱為「H膜」的偏光薄膜。該偏光板可為以乙酸纖維素保護膜所夾持而成的偏光板,或者H膜本身所構成的偏光板。If necessary, a polarizing plate can be attached to the outer surface of the liquid crystal cell to obtain a liquid crystal display element. The polarizing plate attached to the outer surface of the liquid crystal cell is, for example, a polarizing film called "H film" that extends and aligns polyvinyl alcohol and absorbs iodine at the same time. The polarizing plate can be a polarizing plate sandwiched by a cellulose acetate protective film, or a polarizing plate composed of the H film itself.

本發明將就以下實施例作進一步說明,但應瞭解的是,該實施例僅為例示說明之用,而不應被解釋為本發明實施之限制。The present invention will be further described with respect to the following embodiments, but it should be understood that the embodiments are only for illustrative purposes and should not be interpreted as limitations on the implementation of the present invention.

製備例1     第一聚合物(A1)--聚醯亞胺前驅物Preparation Example 1     First polymer (A1)--polyimide precursor

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.035莫耳的 、0.01莫耳的 、0.005莫耳的 及80克的N-甲基-2-吡咯烷酮,並於室溫下攪拌至溶解。接著,加入0.04975莫耳的 、0.00025莫耳的 及20克的N-甲基-2-吡咯烷酮,並於室溫下反應2小時,獲得反應溶液。將該反應溶液倒入1500毫升的水中,以析出聚合物,然後,進行過濾處理,獲得濾餅,接著,以甲醇清洗該濾餅,然後,進行過濾,其中,以甲醇清洗並過濾,共進行三次。接著,置入真空烘箱中,並以60℃的條件進行乾燥處理,即可製得第一聚合物(A1)。 A 500 ml four-necked conical flask was equipped with a nitrogen inlet, a stirrer, a condenser and a thermometer, and nitrogen was introduced. Then, 0.035 mol of , 0.01 mol , 0.005 mol and 80 g of N-methyl-2-pyrrolidone and stirred at room temperature until dissolved. Then, 0.04975 mol of , 0.00025 mol and 20 g of N-methyl-2-pyrrolidone, and react at room temperature for 2 hours to obtain a reaction solution. The reaction solution is poured into 1500 ml of water to precipitate a polymer, and then filtered to obtain a filter cake. Then, the filter cake is washed with methanol and then filtered, wherein the washing and filtering with methanol are performed three times in total. Then, it is placed in a vacuum oven and dried at 60° C. to obtain a first polymer (A1).

製備例2至5、製備例7及比較製備例1至2Preparation Examples 2 to 5, Preparation Example 7 and Comparative Preparation Examples 1 to 2

製備例2至5、製備例7及比較製備例1至2的製備方法大致與製備例1類似,不同在於改變四羧酸二酐組份(a1)及二胺組份(b1)的種類或用量,如表1所示。The preparation methods of Preparation Examples 2 to 5, Preparation Example 7 and Comparative Preparation Examples 1 to 2 are generally similar to Preparation Example 1, except that the types or amounts of the tetracarboxylic dianhydride component (a1) and the diamine component (b1) are changed, as shown in Table 1.

製備例6--醯亞胺化聚合物Preparation Example 6 - Imidization Polymer

在一容積500毫升的四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.035莫耳的 、0.01莫耳的 、0.005莫耳的 及80克的N-甲基-2-吡咯烷酮,並於室溫下攪拌至溶解。接著,加入0.04莫耳的 、0.005莫耳的 、0.005莫耳的 及20克的N-甲基-2-吡咯烷酮,並於室溫下反應6小時,然後,加入97克的N-甲基-2-吡咯烷酮、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應,獲得反應溶液。將該反應溶液倒入1500毫升的水中,以析出聚合物。然後,進行過濾處理,獲得濾餅,接著,以甲醇清洗該濾餅,然後,進行過濾,其中,以甲醇清洗並過濾,共進行三次。接著,置入真空烘箱中,以60℃的條件進行乾燥處理,即可製得第一聚合物(A1)。 A 500 ml four-necked conical flask was equipped with a nitrogen inlet, a stirrer, a condenser and a thermometer, and nitrogen was introduced. Then, 0.035 mol of , 0.01 mol , 0.005 mol and 80 g of N-methyl-2-pyrrolidone and stirred at room temperature until dissolved. Then, 0.04 mol of , 0.005 mol , 0.005 mol and 20 grams of N-methyl-2-pyrrolidone, and react at room temperature for 6 hours, then add 97 grams of N-methyl-2-pyrrolidone, 2.55 grams of acetic anhydride and 19.75 grams of pyridine, raise the temperature to 60°C, and continue stirring for 2 hours to carry out an imidization reaction to obtain a reaction solution. The reaction solution is poured into 1500 milliliters of water to precipitate a polymer. Then, it is filtered to obtain a filter cake, and then the filter cake is washed with methanol, and then filtered, wherein the washing and filtering with methanol are carried out three times. Then, it is placed in a vacuum oven and dried at 60°C to obtain the first polymer (A1).

表1 單位:莫耳% 製備例 比較製備例 1 2 3 4 5 6 7 1 2 四羧酸二酐組份(a1) a1-1-a 99.5 95 80 50 90 80 40 90 0 a1-1-b 0.5 5 20 50 5 10 50 0 0 a1-2-a 0 0 0 0 5 0 10 10 0 a1-2-b 0 0 0 0 0 10 0 0 0 a1-2-c 0 0 0 0 0 0 0 0 100 二胺組份(b1) b1-1-a 70 0 60 10 70 0 0 70 70 b1-1-b 0 70 0 50 0 70 70 0 0 b1-2-a 20 0 20 0 20 0 20 20 20 b1-2-b 0 20 0 20 0 20 0 0 0 b1-3-a 10 10 20 10 10 10 10 10 10 b1-3-b 0 0 0 10 0 0 0 0 0 a1-1-a: ;a1-1-b: ;a1-2-a: ;a1-2-b: ;a1-2-c: ; b1-1-a: ; b1-1-b: ; b1-2-a: ; b1-2-b: ; b1-3-a: ; b1-3-b: Table 1 Unit: mole% Preparation example Comparison of preparation examples 1 2 3 4 5 6 7 1 2 Tetracarboxylic dianhydride component (a1) a1-1-a 99.5 95 80 50 90 80 40 90 0 a1-1-b 0.5 5 20 50 5 10 50 0 0 a1-2-a 0 0 0 0 5 0 10 10 0 a1-2-b 0 0 0 0 0 10 0 0 0 a1-2-c 0 0 0 0 0 0 0 0 100 Diamine component (b1) b1-1-a 70 0 60 10 70 0 0 70 70 b1-1-b 0 70 0 50 0 70 70 0 0 b1-2-a 20 0 20 0 20 0 20 20 20 b1-2-b 0 20 0 20 0 20 0 0 0 b1-3-a 10 10 20 10 10 10 10 10 10 b1-3-b 0 0 0 10 0 0 0 0 0 a1-1-a: ; a1-1-b: ; a1-2-a: ; a1-2-b: ; a1-2-c: ; b1-1-a: ; b1-1-b: ; b1-2-a: ; b1-2-b: ; b1-3-a: ; b1-3-b:

製備例8      第二聚合物(A2)--聚醯亞胺前驅物Preparation Example 8 Second polymer (A2) - polyimide precursor

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.04莫耳的 、0.01莫耳的 及80克的N-甲基-2-吡咯烷酮,並於室溫下攪拌至溶解。接著,加入0.05莫耳的 及20克的N-甲基-2-吡咯烷酮,並於室溫下反應2小時,獲得反應溶液。將該反應溶液倒入1500毫升的水中,以析出聚合物,然後,進行過濾處理,獲得濾餅,接著,以甲醇清洗該濾餅,然後,進行過濾,其中,以甲醇清洗並過濾,共進行三次。接著,置入真空烘箱中,並以60℃的條件進行乾燥處理,即可製得第二聚合物(A2)。 A 500 ml four-necked conical flask was equipped with a nitrogen inlet, a stirrer, a condenser and a thermometer, and nitrogen was introduced. Then, 0.04 mol of , 0.01 mol and 80 g of N-methyl-2-pyrrolidone and stirred at room temperature until dissolved. Then, 0.05 mol of and 20 g of N-methyl-2-pyrrolidone, and react at room temperature for 2 hours to obtain a reaction solution. The reaction solution is poured into 1500 ml of water to precipitate a polymer, and then filtered to obtain a filter cake. Then, the filter cake is washed with methanol and then filtered, wherein the washing and filtering with methanol are performed three times in total. Then, it is placed in a vacuum oven and dried at 60° C. to obtain a second polymer (A2).

製備例9至10Preparation Examples 9 to 10

製備例9至10的製備方法大致與製備例8類似,不同在於改變四羧酸二酐組份(a2)及二胺組份(b2)的種類或用量,如表2所示。The preparation methods of Preparation Examples 9 to 10 are generally similar to Preparation Example 8, except that the types or amounts of the tetracarboxylic dianhydride component (a2) and the diamine component (b2) are changed, as shown in Table 2.

表2 單位:莫耳% 製備例 8 9 10 四羧酸二酐組份(a2) a2-a 100 100 0 a2-b 0 0 100 二胺組份(b2) b2-a 80 20 100 b2-b 20 0 0 b2-c 0 80 0 a2-a: ;a2-b: ; b2-a: ;b2-b: ; b2-c: Table 2 Unit: mole% Preparation example 8 9 10 Tetracarboxylic dianhydride component (a2) a2-a 100 100 0 a2-b 0 0 100 Diamine component (b2) b2-a 80 20 100 b2-b 20 0 0 b2-c 0 80 0 a2-a: ; a2-b: ; b2-a: ; b2-b: ; b2-c:

實施例1Embodiment 1

將100重量份的製備例7的第一聚合物及1200重量份的N-甲基-2-吡咯烷酮,並於室溫下攪拌混合,獲得液晶配向劑。100 parts by weight of the first polymer of Preparation Example 7 and 1200 parts by weight of N-methyl-2-pyrrolidone were stirred and mixed at room temperature to obtain a liquid crystal alignment agent.

實施例2至14及比較例1至2Examples 2 to 14 and Comparative Examples 1 to 2

該實施例2至14的製備方法及比較例1至2大致與實施例1類似,不同在於改變第一聚合物及第二聚合物的種類或用量,或者,溶劑的種類,如表3所示。The preparation methods of Examples 2 to 14 and Comparative Examples 1 to 2 are substantially similar to those of Example 1, except that the types or amounts of the first polymer and the second polymer, or the types of solvents, are changed, as shown in Table 3.

應用例1      液晶顯示元件Application Example 1: Liquid Crystal Display Components

將實施例1的液晶配向劑以旋轉塗佈方式塗佈在包含畫素電極的玻璃基板的畫素電極上,其中,該畫素電極為具有一對氧化銦錫(ITO)電極(電極寬為10μm,電極間隔為10μm,而電極高度為50nm)的IPS驅動用電極,該對ITO電極的形狀為櫛齒狀,且彼此的櫛齒狀部份是以分開並咬合的方式來配置。然後,將塗佈有液晶配向劑的玻璃基板在80℃的加熱板上乾燥3分鐘,接著,在250℃的熱風循環式烘箱中烘烤30分鐘,而獲得形成在該玻璃基板上且膜厚為100nm的塗膜。透過一偏光板,對該塗膜照射波長為254nm的紫外線,然後,在250℃的熱風循環式烘箱中烘烤30分鐘,獲得包含液晶配向膜的第一積層體。The liquid crystal alignment agent of Example 1 is applied on a pixel electrode of a glass substrate including a pixel electrode by rotational coating, wherein the pixel electrode is an IPS driving electrode having a pair of indium tin oxide (ITO) electrodes (electrode width is 10 μm, electrode spacing is 10 μm, and electrode height is 50 nm), and the pair of ITO electrodes are in a comb-tooth shape, and the comb-tooth portions of each other are configured in a separated and interlocking manner. Then, the glass substrate coated with the liquid crystal alignment agent was dried on a heating plate at 80°C for 3 minutes, and then baked in a hot air circulation oven at 250°C for 30 minutes to obtain a coating with a thickness of 100 nm formed on the glass substrate. The coating was irradiated with ultraviolet light with a wavelength of 254 nm through a polarizing plate, and then baked in a hot air circulation oven at 250°C for 30 minutes to obtain a first laminate including a liquid crystal alignment film.

將實施例1的液晶配向劑以旋轉塗佈方式塗佈在未有畫素電極且具有高度為4μm的柱狀間隔件的玻璃基板上,然後,將塗佈有液晶配向劑的玻璃基板在80℃的加熱板上乾燥3分鐘,接著,在250℃的熱風循環式烘箱中烘烤30分鐘,而獲得形成在該玻璃基板上且膜厚為100nm的塗膜。透過一偏光板,對該塗膜照射波長為254nm的紫外線,然後,在250℃的熱風循環式烘箱中烘烤30分鐘,獲得包含液晶配向膜的第二積層體。The liquid crystal alignment agent of Example 1 was applied by rotational coating on a glass substrate having no pixel electrodes and columnar spacers with a height of 4 μm, and then the glass substrate coated with the liquid crystal alignment agent was dried on a heating plate at 80° C. for 3 minutes, and then baked in a hot air circulation oven at 250° C. for 30 minutes to obtain a coating film with a thickness of 100 nm formed on the glass substrate. The coating film was irradiated with ultraviolet light with a wavelength of 254 nm through a polarizing plate, and then baked in a hot air circulation oven at 250° C. for 30 minutes to obtain a second laminate including a liquid crystal alignment film.

在該第一積層體及該第二積層體中一者上印刷密封劑,然後,將該第一積層體的液晶配向膜與該二積層體的液晶配向膜相對且配向方向為0°的方式,貼合在一起,然後,使該密封劑硬化,獲得包含注入口及連通該注入口的液晶晶胞空穴的積層體。接著,以減壓注入法,將液晶MLC-2041(Merck公司製)注入於該液晶晶胞空穴中,並密封該注入口,獲得包含該積層體及液晶的液晶單元。然後,將偏光板彼此垂直地附接至該液晶單元的積層體的頂面和底面,形成液晶顯示元件。A sealant is printed on one of the first laminate and the second laminate, and then the liquid crystal alignment film of the first laminate is bonded together with the liquid crystal alignment film of the second laminate facing each other and with the alignment direction being 0°, and then the sealant is cured to obtain a laminate including an injection port and a liquid crystal cell cavity connected to the injection port. Then, liquid crystal MLC-2041 (manufactured by Merck) is injected into the liquid crystal cell cavity by a reduced pressure injection method, and the injection port is sealed to obtain a liquid crystal unit including the laminate and liquid crystal. Then, polarizing plates are attached perpendicularly to the top and bottom surfaces of the laminate of the liquid crystal unit to form a liquid crystal display element.

應用例2至14及比較應用例1至2Application Examples 2 to 14 and Comparative Application Examples 1 to 2

該應用例2至14及比較應用例1至2的製備方法大致與應用例1類似,不同在於該應用例2至12及比較應用例1至2的液晶配向劑依序為實施例2至14及比較例1至2的液晶配向劑。The preparation methods of application examples 2 to 14 and comparative application examples 1 to 2 are substantially similar to that of application example 1, except that the liquid crystal alignment agents of application examples 2 to 12 and comparative application examples 1 to 2 are the liquid crystal alignment agents of embodiments 2 to 14 and comparative examples 1 to 2, respectively.

表3 單位:重量份 實施例 1 2 3 4 5 6 7 8 聚合物組份(A) 第一聚合物(A1) 製備例 1 0 100 0 0 0 0 0 0 2 0 0 100 0 0 0 0 0 3 0 0 0 100 0 0 0 0 4 0 0 0 0 100 0 0 0 5 0 0 0 0 0 100 0 0 6 0 0 0 0 0 0 100 0 7 100 0 0 0 0 0 0 90 比較製備例 1 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 第二聚合物(A2) 製備例 8 0 0 0 0 0 0 0 10 9 0 0 0 0 0 0 0 0 10 0 0 0 0 0 0 0 0 溶劑(B) N-甲基-2-吡咯烷酮 1200 0 1200 N-乙基-2-吡咯烷酮 0 1200 0 Table 3 Unit: Weight Embodiment 1 2 3 4 5 6 7 8 Polymer component (A) First polymer (A1) Preparation example 1 0 100 0 0 0 0 0 0 2 0 0 100 0 0 0 0 0 3 0 0 0 100 0 0 0 0 4 0 0 0 0 100 0 0 0 5 0 0 0 0 0 100 0 0 6 0 0 0 0 0 0 100 0 7 100 0 0 0 0 0 0 90 Comparison of preparation examples 1 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 Second polymer (A2) Preparation example 8 0 0 0 0 0 0 0 10 9 0 0 0 0 0 0 0 0 10 0 0 0 0 0 0 0 0 Solvent (B) N-Methyl-2-pyrrolidone 1200 0 1200 N-Ethyl-2-pyrrolidone 0 1200 0

表4 實施例 比較例 9 10 11 12 13 14 1 2 聚合物組份(A) 第一聚合物(A1) 製備例 1 0 20 0 0 0 0 0 0 2 0 0 30 0 0 0 0 0 3 0 0 0 40 0 0 0 0 4 0 0 0 0 50 0 0 0 5 0 0 0 0 0 60 0 0 6 0 0 0 0 0 0 0 0 7 30 0 0 0 0 0 0 0 比較製備例 1 0 0 0 0 0 0 0 100 2 0 0 0 0 0 0 100 0 第二聚合物(A2) 製備例 8 70 0 70 0 0 30 0 0 9 0 0 0 60 0 0 0 0 10 0 80 0 0 50 0 0 0 溶劑(B) N-甲基-2-吡咯烷酮 1200 N-乙基-2-吡咯烷酮 0 Table 4 Embodiment Comparison Example 9 10 11 12 13 14 1 2 Polymer component (A) First polymer (A1) Preparation example 1 0 20 0 0 0 0 0 0 2 0 0 30 0 0 0 0 0 3 0 0 0 40 0 0 0 0 4 0 0 0 0 50 0 0 0 5 0 0 0 0 0 60 0 0 6 0 0 0 0 0 0 0 0 7 30 0 0 0 0 0 0 0 Comparison of preparation examples 1 0 0 0 0 0 0 0 100 2 0 0 0 0 0 0 100 0 Second polymer (A2) Preparation example 8 70 0 70 0 0 30 0 0 9 0 0 0 60 0 0 0 0 10 0 80 0 0 50 0 0 0 Solvent (B) N-Methyl-2-pyrrolidone 1200 N-Ethyl-2-pyrrolidone 0

評價項目Evaluation items

殘影性測試:以10V的交流電壓驅動應用例1至14及比較應用例1至2的液晶單元30小時,然後,將該液晶單元夾設在一台光學設備的一起偏器與一檢偏器間,接著,利用該光學設備量測該液晶單元的光透過量,並計算出最小相對透過率(%)。該光學設備包含光源、一光量檢測器及在該光源與該光量檢測器間配置的一偏光裝置,且該偏光裝置包括該起偏器及該檢偏器。 最小相對透過率(%)=[(β-B0)/(B100-B0)]×100% B0為空白(blank),且為正交尼科耳(crossed nicols)下的光透過量,即暗態時光透過量; B100為空白(blank),且為平行尼科耳(parallel nicols)下的光透過量,即亮態時光透過量; β為正交尼科耳下,液晶單元的最小光透過量。 液晶顯示元件的暗態黑色水平的程度,是以液晶顯示元件的最小相對透過率來表示。當該最小相對透過率越小,表示殘影性越低。評價基準為: ◎表示最小相對透過率≦0.5%; O表示0.5%<最小相對透過率≦1.0%; △表示1.0%<最小相對透過率≦1.5%; X表示最小相對透過率>1.5%。 Afterimage test: The liquid crystal units of application examples 1 to 14 and comparison application examples 1 to 2 are driven with an AC voltage of 10V for 30 hours, and then the liquid crystal unit is sandwiched between a polarizer and an analyzer of an optical device. Then, the light transmittance of the liquid crystal unit is measured using the optical device, and the minimum relative transmittance (%) is calculated. The optical device includes a light source, a light detector, and a polarizing device arranged between the light source and the light detector, and the polarizing device includes the polarizer and the analyzer. Minimum relative transmittance (%) = [(β-B0)/(B100-B0)] × 100% B0 is blank and is the light transmittance under crossed nicols, i.e., the light transmittance in the dark state; B100 is blank and is the light transmittance under parallel nicols, i.e., the light transmittance in the bright state; β is the minimum light transmittance of the liquid crystal unit under crossed nicols. The degree of the dark black level of the liquid crystal display element is expressed by the minimum relative transmittance of the liquid crystal display element. The smaller the minimum relative transmittance, the lower the afterimage. The evaluation criteria are: ◎ indicates minimum relative transmittance ≤ 0.5%; O indicates 0.5% < minimum relative transmittance ≤ 1.0%; △ indicates 1.0% < minimum relative transmittance ≤ 1.5%; X indicates minimum relative transmittance > 1.5%.

閃爍度測試:將應用例1至14及比較應用例1至2的液晶單元設置於偏光軸以垂直交叉方式配置的兩片偏光板間,然後,於未對該液晶單元施加電壓的狀態下,點亮LED背光源,並調整該液晶單元的配置角度,以使通過該液晶單元的光線的亮度達最小的狀態。接著,對該液晶單元施加頻率為30Hz的交流電壓,且利用檢測設備量測出電壓及光透過量,並獲得電壓-光透過率的曲線圖,接著,利用該曲線圖,計算出相對光透過率為23%的交流電壓,以作為驅動電壓。然後,將該液晶單元的溫度控制在23℃的狀態,並關閉已點亮的LED背光源,接著,在未照光狀態下置放72小時間,然後,點亮LED背光源,並於點亮開始的同時,以相對光透過率為23%的頻率為30Hz的交流電壓驅動該液晶單元60分鐘,接著,使用與LED背光源及I-V變換增幅器連接的資料擷取/資料記錄切換裝置(Agilent technologies公司製;型號為34970A),追蹤該液晶單元的閃爍振幅,並讀取通過兩片偏光板及該液晶單元的亮度值,然後,利用該閃爍振幅及該亮度值,計算出閃爍度。 閃爍度(%)=[閃爍振幅/(2×亮度值)]×100% 當閃爍度越低,表示液晶顯示元件的品質越佳。評價基準為◎表示閃爍度<3%;O表示4%>閃爍度≧3%;△表示5%>閃爍度≧4%;X表示閃爍度≧5%。 Flicker test: Place the liquid crystal unit of application examples 1 to 14 and comparison application examples 1 to 2 between two polarizers whose polarization axes are arranged in a vertically crossed manner. Then, without applying voltage to the liquid crystal unit, light up the LED backlight source, and adjust the configuration angle of the liquid crystal unit so that the brightness of the light passing through the liquid crystal unit is minimized. Then, apply an AC voltage with a frequency of 30Hz to the liquid crystal unit, and use the detection equipment to measure the voltage and light transmittance, and obtain a curve of voltage-light transmittance. Then, use the curve to calculate the AC voltage with a relative light transmittance of 23% as the driving voltage. Then, the temperature of the liquid crystal unit was controlled at 23°C, and the LED backlight that was turned on was turned off. Then, it was placed in a non-illuminated state for 72 hours. Then, the LED backlight was turned on, and at the same time as the lighting started, the liquid crystal unit was driven for 60 minutes with an AC voltage of 30Hz with a relative light transmittance of 23%. Then, a data acquisition/data recording switching device (made by Agilent technologies; model 34970A) connected to the LED backlight and the I-V conversion amplifier was used to track the flicker amplitude of the liquid crystal unit and read the brightness value passing through the two polarizing plates and the liquid crystal unit. Then, the flicker degree was calculated using the flicker amplitude and the brightness value. Flicker (%) = [Flicker amplitude/(2×brightness value)]×100% The lower the flicker, the better the quality of the LCD display element. The evaluation criteria are: ◎ means flicker <3%; O means 4%> flicker ≧3%; △ means 5%> flicker ≧4%; X means flicker ≧5%.

表5 最小相對透過率(%) 閃爍度(%) 應用例 1 O O 2 O 3 O 4 O 5 O 6 O 7 O 8 O O 9 O 10 11 12 13 14 比較應用例 1 X O 2 X O Table 5 Minimum relative transmittance (%) Flicker(%) Application Examples 1 O O 2 O 3 O 4 O 5 O 6 O 7 O 8 O O 9 O 10 11 12 13 14 Comparison Applications 1 X O 2 X O

由表3至表5的實驗可知,在實施例1至7的液晶配向劑中,使用的製備例1至7的第一聚合物採用了式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物,致使包含採用該等第一聚合物的實施例1至7的液晶配向劑的液晶顯示元件於驅動後的最小相對透過率為O至◎,由此可知,本發明使用具有式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物的聚合物的液晶配向劑所形成的液晶顯示元件不易有影像殘留的問題,而在比較例1至2中,使用的比較合成例1至2的聚合物未採用式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物,致使包含採用比較合成例1至2的聚合物的液晶配向劑的液晶顯示元件於驅動後的最小相對透過率為X,由此可知,未使用具有式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物的聚合物的液晶配向劑所形成的液晶顯示元件容易發生影像殘留的現象。由上述可知,本發明使用式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物的第一聚合物的液晶配向劑確實能夠有效地降低殘影性。From the experiments in Tables 3 to 5, it can be seen that in the liquid crystal alignment agents of Examples 1 to 7, the first polymers used in Preparation Examples 1 to 7 adopt the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II), so that the minimum relative transmittance of the liquid crystal display element after driving, which includes the liquid crystal alignment agents of Examples 1 to 7 using the first polymers, is 0 to ◎. Therefore, it can be seen that the liquid crystal display element formed by the liquid crystal alignment agent of the present invention using the polymer of the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II) The problem of image residue is not easy to occur. In Comparative Examples 1 to 2, the polymers of Comparative Synthesis Examples 1 to 2 used do not use the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II), so that the minimum relative transmittance of the liquid crystal display element containing the liquid crystal alignment agent using the polymers of Comparative Synthesis Examples 1 to 2 after driving is X. Therefore, it can be seen that the liquid crystal display element formed by the liquid crystal alignment agent that does not use the polymer having the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II) is prone to image residue. From the above, it can be seen that the liquid crystal alignment agent of the present invention using the first polymer of the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II) can indeed effectively reduce the image residue.

再者,相較於實施例1至7的液晶配向劑,在實施例9至14的液晶配向劑中,進一步還包含第二聚合物(A2),且在該第二聚合物的參與下,包含由實施例9至14的液晶配向劑所形成的液晶配向膜的液晶顯示元件在驅動後的閃爍度的表現上是明顯地降低。由上述可知,本發明的液晶配向劑不僅具有低殘影性,同時,還能夠兼具畫面不易閃爍的優點。Furthermore, compared to the liquid crystal alignment agents of Examples 1 to 7, the liquid crystal alignment agents of Examples 9 to 14 further include a second polymer (A2), and with the participation of the second polymer, the liquid crystal display element including the liquid crystal alignment film formed by the liquid crystal alignment agents of Examples 9 to 14 has significantly reduced flicker after being driven. As can be seen from the above, the liquid crystal alignment agent of the present invention not only has low afterimage, but also has the advantage of low screen flicker.

綜上所述,透過使用式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物,由本發明液晶配向劑所形成的液晶配向膜用於液晶顯示元件中,能夠賦予該液晶顯示元件具有低殘影性的優點,而能夠滿足應用需求,故確實能達成本發明的目的。In summary, by using the tetracarboxylic dianhydride compound represented by formula (I) and the tetracarboxylic dianhydride compound represented by formula (II), the liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention is used in a liquid crystal display element, which can give the liquid crystal display element the advantage of low afterimage and can meet application requirements, thereby truly achieving the purpose of the present invention.

惟以上所述者,僅為本發明的實施例而已,當不能以此限定本發明實施的範圍,凡是依本發明申請專利範圍及專利說明書內容所作的簡單的等效變化與修飾,皆仍屬本發明專利涵蓋的範圍內。However, the above is only an embodiment of the present invention and should not be used to limit the scope of implementation of the present invention. All simple equivalent changes and modifications made according to the scope of the patent application of the present invention and the content of the patent specification are still within the scope of the present patent.

Claims (6)

一種液晶配向劑,包含:聚合物組份(A),包含第一聚合物(A1),且該第一聚合物(A1)是由第一混合物反應而製得,而該第一混合物包含四羧酸二酐組份(a1)及二胺組份(b1);及溶劑(B),其中,該四羧酸二酐組份(a1)包括四羧酸二酐化合物混合物(a1-1),且該四羧酸二酐混合物(a1-1)是由式(I)所示的四羧酸二酐化合物及式(II)所示的四羧酸二酐化合物所組成,
Figure 112145425-A0305-02-0064-1
基於該四羧酸二酐組份(a1)的總使用量為100莫耳,該式(I)所示的四羧酸二酐化合物的使用量為50莫耳至99.5莫耳,且該式(II)所示的四羧酸二酐化合物的使用量為0.5莫耳至50莫耳。
A liquid crystal alignment agent comprises: a polymer component (A) comprising a first polymer (A1), wherein the first polymer (A1) is prepared by reacting a first mixture, wherein the first mixture comprises a tetracarboxylic dianhydride component (a1) and a diamine component (b1); and a solvent (B), wherein the tetracarboxylic dianhydride component (a1) comprises a tetracarboxylic dianhydride compound mixture (a1-1), and the tetracarboxylic dianhydride mixture (a1-1) is composed of a tetracarboxylic dianhydride compound represented by formula (I) and a tetracarboxylic dianhydride compound represented by formula (II),
Figure 112145425-A0305-02-0064-1
Based on the total usage of the tetracarboxylic dianhydride component (a1) being 100 mol, the usage of the tetracarboxylic dianhydride compound represented by formula (I) is 50 mol to 99.5 mol, and the usage of the tetracarboxylic dianhydride compound represented by formula (II) is 0.5 mol to 50 mol.
如請求項1所述的液晶配向劑,其中,基於該聚合物組份(A)的使用量為100重量份,該溶劑(B)的使用量為800重量份至3000重量份。 The liquid crystal alignment agent as described in claim 1, wherein the amount of the polymer component (A) used is 100 parts by weight, and the amount of the solvent (B) used is 800 parts by weight to 3000 parts by weight. 如請求項1所述的液晶配向劑,其中,該聚合物組份(A)還包含第二聚合物(A2),且該第二聚合物(A2)選自於由聚醯亞胺前驅物及聚醯亞胺前驅物所形成的醯亞胺化聚合 物所組成的群組中至少一者,該第二聚合物(A2)的聚醯亞胺前驅物不包含該第一聚合物(A1)的四羧酸二酐混合物(a1-1)。 The liquid crystal alignment agent as described in claim 1, wherein the polymer component (A) further comprises a second polymer (A2), and the second polymer (A2) is selected from at least one of the group consisting of a polyimide precursor and an imidized polymer formed by the polyimide precursor, and the polyimide precursor of the second polymer (A2) does not comprise the tetracarboxylic dianhydride mixture (a1-1) of the first polymer (A1). 如請求項3所述的液晶配向劑,其中,基於該聚合物組份(A)為100重量份,該第一聚合物(A1)的使用量為5至85重量份,而該第二聚合物(A2)的使用量為15至95重量份。 The liquid crystal alignment agent as described in claim 3, wherein, based on 100 parts by weight of the polymer component (A), the amount of the first polymer (A1) used is 5 to 85 parts by weight, and the amount of the second polymer (A2) used is 15 to 95 parts by weight. 一種液晶配向膜,是由如請求項1至4中任一項所述的液晶配向劑所形成。 A liquid crystal alignment film is formed by a liquid crystal alignment agent as described in any one of claims 1 to 4. 一種液晶顯示元件,包含如請求項5所述的液晶配向膜。 A liquid crystal display element, comprising a liquid crystal alignment film as described in claim 5.
TW112145425A 2023-11-23 2023-11-23 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TWI859005B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW112145425A TWI859005B (en) 2023-11-23 2023-11-23 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN202411587192.0A CN120025832A (en) 2023-11-23 2024-11-08 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW112145425A TWI859005B (en) 2023-11-23 2023-11-23 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Publications (2)

Publication Number Publication Date
TWI859005B true TWI859005B (en) 2024-10-11
TW202521673A TW202521673A (en) 2025-06-01

Family

ID=94084016

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112145425A TWI859005B (en) 2023-11-23 2023-11-23 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (2)

Country Link
CN (1) CN120025832A (en)
TW (1) TWI859005B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201902985A (en) * 2017-06-13 2019-01-16 奇美實業股份有限公司 Method for manufacturing liquid crystal alignment film and liquid crystal display element
TW202120592A (en) * 2019-11-27 2021-06-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202321428A (en) * 2021-08-06 2023-06-01 日商日產化學股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201902985A (en) * 2017-06-13 2019-01-16 奇美實業股份有限公司 Method for manufacturing liquid crystal alignment film and liquid crystal display element
TW202120592A (en) * 2019-11-27 2021-06-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202321428A (en) * 2021-08-06 2023-06-01 日商日產化學股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Also Published As

Publication number Publication date
TW202521673A (en) 2025-06-01
CN120025832A (en) 2025-05-23

Similar Documents

Publication Publication Date Title
KR20250043437A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP7800532B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI859005B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI865340B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI858879B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI889344B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal photo alignment film and liquid crystal display element
TWI887964B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI888820B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI901102B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI911714B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI897382B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TW202146528A (en) Liquid crystal alignment agent for photo-alignment process, liquid crystal alignment film, and liquid crystal display component which may obtain high liquid crystal alignment by means of a photo-alignment process, and suppress a deviation of in-plane luminance during black display
TWI905717B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI903532B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI892269B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI863615B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI902144B (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TWI890820B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN120290193A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method
CN120829783A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method
CN120829782A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method
CN120399717A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display component for photo-alignment method
TW202542287A (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TW202542286A (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element
TW202546199A (en) Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element